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Abstract 
Altitude training is frequently used by elite athletes to obtain potential benefits in sea-level 
performance. One of the main recognized physiological adaptations leading to enhanced sea-
level performance is a hypoxia-induced increase in hemoglobin mass (Hbmass). During the last 
decades, several types of altitude training have been developed, which can be performed under 
either hypobaric hypoxia (HH, natural altitude) or normobaric hypoxia (NH, simulated 
altitude). Whether NH and HH can be used interchangeably for altitude training is still unclear. 
Moreover, especially from an athlete’s perspective, the individual adaptations to and the 
interchangeability of NH and HH are of interest. 
Therefore, to compare individual and mean Hbmass responses during an 18-day live hightrain 
low (LHTL) altitude training camp in either NH or HH, we designed a randomized matched 
controlled (n = 28) study and a crossover (n = 15) study with endurance athletes. To more 
precisely quantify the individual Hbmass response to altitude training, we implemented error-
reducing duplicate Hbmass measures. Furthermore, since altitude training is primarily used by 
elite endurance athletes that typically present elevated Hbmass values, we tested the hypothesis 
that athletes with a high initial Hbmass starting an altitude sojourn will have a limited ability to 
further increase their post-altitude Hbmass in male endurance and team-sport athletes (n = 58). 
The present thesis indicates that hypobaric and normobaric LHTL camps evoke a similar mean 
increase in Hbmass as well as similar performance changes following an 18-day LHTL camp, 
suggesting that both hypoxic conditions can be used equally for an LHTL training camp. 
Among the mean Hbmass changes, there was a notable inter-individual variation that could not 
be explained by the variation in the initial Hbmass. This emphasizes the importance of individual 
Hbmass response evaluation for altitude training in athletes. 
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Résumé (Abstract in French) 
L’entrainement en altitude est couramment utilisé par les sportifs d’élites afin d’obtenir des 
bénéfices améliorant la performance au niveau de la mer. Le mécanisme-clef réside dans 
l’augmentation de la masse totale en hémoglobine (Hbmass) induite par l’hypoxie. Ces dernières 
décennies, plusieurs méthodes d’entrainement en altitude ont été développées, soit en hypoxie 
hypobare (HH, altitude réelle) soit en hypoxie normobare (NH, altitude simulée). La question 
de savoir si HH et NH sont interchangeables n’est pas encore complètement résolue. En 
particulier, les effets de NH vs. HH sur les réponses individuelles de Hbmass sont encore mal 
connus. 
Par conséquent, afin de comparer les réponses de Hbmass au cours d’un stage de 18 jours "vivre 
en haut et s’entrainer en bas, LHTL" soit en NH ou en HH, nous avons réalisé un protocole 
randomisé contrôlé (n = 28) puis un protocole croisé (n = 15) avec des athlètes d’endurance. 
Afin de quantifier plus précisément les réponses individuelles de Hbmass et de réduire les erreurs, 
les mesures ont été dupliquées. De plus, comme l’entrainement en altitude est utilisé à ce jour 
principalement par les athlètes d’endurance ayant un niveau initial élevé de Hbmass, nous avons 
testé l’hypothèse que les athlètes ayant une haute valeur de Hbmass ont une augmentation limitée 
de celle-ci suite à un stage en altitude, que ce soit avec des sportifs d’endurance ou de sport 
collectif (n = 58). 
Le travail de doctorat réalisé montre que LHTL induit la même augmentation de Hbmass en 
hypoxie normobare et hypobare, ainsi qu’une amélioration similaire de la performance aérobie. 
Aussi, les deux conditions hypoxiques (HH et NH) peuvent être utilisées pour des stages de 
type LHTL. De plus, une variabilité importante interindividuelle des réponses de Hbmass a été 
rapportée, qui ne dépendent pas du niveau initial de Hbmass des sujets. Ceci met en évidence la 
nécessité de mesurer ces réponses individuelles avec précision.  
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1. Introduction 
The general introduction provides an overview of the current altitude training methods, the 
erythropoietic response to altitude exposure, and the measurement principles of hemoglobin 
mass (Hbmass). The second part of the introduction, “hemoglobin mass response to normobaric 
and hypobaric hypoxia”, is more specific and introduces the topic of the present thesis. 
1.1 General introduction 
1.1.1 Altitude training methods 
Athletes frequently use different altitude training methods for potential benefits in sea-level 
performance (7, 94, 107). The main rationale behind altitude training is that the body responds 
to a hypoxic environment (lower oxygen availability in the air and within the body) by an 
enhanced red cell production, resulting in an improved oxygen-carrying capacity, which in turn 
should produce in a better aerobic performance at sea level (12). During the last decades, 
various altitude or hypoxic training methods for athletes have been developed (67, 104). The 
different methods include the traditional “live high–train high” (LHTH), the “live high–train 
low” (LHTL), and the “live low–train high” (LLTH) approaches (figure 1). 
The traditional LHTH method, where athletes live and train at moderate altitude (18002500 
m) for 2 to 4 weeks (67), was further modified into the LHTL method in the 1990s by Levine 
and Stray-Gundersen (56, 57). In contrast to LHTH, in the LHTL method, the athletes live at 
moderate altitude (2500 m) but train at low altitude or near sea level; this allows them to 
maintain an exercise intensity comparable to sea level as well as to obtain the physiological 
benefits of altitude acclimatization (54, 107). The first implementation of the LHTL method 
was performed at natural altitude, where the athletes lived for 28 days at 2500 m and trained at 
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1250 m (57). Since there are only few suitable places in the world to perform LHTL and LHTL 
is generally associated with a time-consuming travel effort from high to low altitudes, hypoxic 
devices have been developed to simulate an altitude environment at sea level (82, 104). 
Common types of altitude simulation are nitrogen dilution (e.g., normobaric hypoxic rooms or 
apartments), oxygen filtration (e.g., normobaric hypoxic rooms or tents) or pressure reduction 
(e.g., hypobaric hypoxic chambers) (105). In recent years, the use of an artificial LHTL method 
has become more and more popular in athletes, since it provides a more logistically convenient 
environment and a time-efficient way of training (94). Overall, there is a broad consensus that 
the success of altitude training relies on an adequate hypoxic “dose”, corresponding to an 
altitude of >2000 m for >12 h·day-1 and a period of >21 days (59, 82, 94, 107), i.e., 
approximately 300 total hypoxic hours (13). 
 
Figure 1. Different altitude/-hypoxic training methods. Modified from Wilber (105) and expanded by Millet 
et al. (67) and (65), dotted lines. LH = live high; TH = train high; TL = train low; LL = live low; LHTLH = live 
hightrain low and high; IHE = intermittent hypoxic exposure; CHT = continuous hypoxic training; IHT = 
intermittent hypoxic training; RSH = repeated sprint training in hypoxia; IHIT = intermittent hypoxic exposure 
during interval training. 
 
Another altitude training method is LLTH, where athletes live at or near sea level and are 
exposed to short or longer bouts of hypoxia (5180 min) that are repeated over several days or 
weeks (67). LLTH can be performed by the athletes at rest (intermittent hypoxic exposures 
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[IHE]) or during training sessions (intermittent hypoxic training [IHT]) (105). This altitude 
training method was further divided by Millet et al. (65, 67) into four sub-categories: IHE, 
continuous hypoxic training (CHT, >30 min and low intensity), IHT, and repeated sprint 
training in hypoxia (RSH). In contrast to the prolonged altitude training methods (LHTH and 
LHTL), the intermittent hypoxic methods can be more easily integrated into an athlete’s 
training schedule, due to less travel and time effort (44). To date, altitude training has been 
mainly used by endurance athletes (94), but it has become increasingly popular in team sports 
during the last few years (5). Thus, combinations of altitude or hypoxic methods have been 
introduced, such as the “live high–train low and high” (LHTLH = LHTL + IHT/RSH) method 
or the intermittent hypoxic interval training (IHIT = IHE + IHT) (8, 65, 67), in order to better 
fit the team sport’s physical requirements (a combination of aerobic and anaerobic adaptations). 
A recent meta-analysis (7) calculated the overall efficacy of the different altitude methods and 
showed that the natural LHTL method was the best protocol to obtain advantageous endurance 
performance adaptations (14%), in contrast to artificial LHTL, LHTH, and LLTH in semi-
elite and elite athletes. 
1.1.2. Erythropoietic responses to hypoxia 
Hypoxia can be defined as combinations of barometric pressure (PB) and an inspired fraction 
of oxygen (FiO2) that result in an inspired partial pressure of oxygen (PiO2) lower than a 
normoxic value of 150 mmHg (15). Hypoxic conditions occur with increasing altitude 
(reduction in PB, also referred to as “hypobaric hypoxia” [HH]) or in lowoxygen environments 
by reducing the oxygen portion in ambient air (reduction in FiO2, also referred to as 
“normobaric hypoxia” [NH]) (20). Exposure to hypoxia leads to a decrease in PiO2 and a 
subsequent reduction in arterial oxygen pressure (PaO2) and arterial oxygen saturation (SaO2) 
(45). This oxygen deficiency in the blood and muscles is also called “hypoxemia”. 
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The human body responds to hypoxia with hematological and non-hematological adaptations, 
which have the potential to improve athletic performance (figure 2). Thus far, there is strong 
evidence that the primary regulator of hypoxia-mediated cellular adaptations is hypoxia-
inducible factor 1 (HIF-1) (20), a transcription factor that regulates oxygen homeostasis (91). 
The α-subunit of HIF-1 (HIF-1α) is highly oxygen sensitive; under normoxia, it is rapidly 
degraded (half-life ~5min), while under hypoxic conditions, it stabilizes, translocates to the 
nucleus, and dimerizes with the hypoxia-inducible factor 1 (HIF-1, an oxygen-independent 
subunit) to form the stable HIF-1 complex (53). HIF-1 becomes transcriptionally active and 
drives the expression of target genes involved in erythropoiesis (erythropoietin [EPO]), iron 
metabolism (e.g., transferrin and transferrin receptor), angiogenesis (e.g., vascular endothelial 
growth factor [VEGF]), vascular tone (e.g., nitric oxide [NO] synthase) or glucose metabolism 
(e.g., glycolytic enzymes) (53). Overall, the adaptations to hypoxia driven by HIF-1 lead to 
enhanced oxygen transport capacity and/-or improved oxygen extraction/-utilization at the 
cellular level (60). 
One of the main recognized physiological adaptations leading to enhanced aerobic performance 
is a hypoxia-induced increase in erythropoiesis (11, 57, 103). Under hypoxia, erythropoiesis is 
mainly triggered by an enhanced stimulation of the EPO hormone in the kidneys (52). After 
arrival at altitude, EPO increases within hours and peaks after 1 to 2 days of hypoxic exposure, 
before it declines toward baseline (52, 75). The increased EPO levels lead to an enhanced 
production of red blood cells (RBC) in the bone marrow, resulting in an elevated Hbmass and 
thus an improved oxygen transport capacity of the blood, which in turn should enhance exercise 
performance (58, 96, 102, 107). In the original paper by Levine and Stray-Gundersen that 
presents the LHTL training model (57), the results demonstrated that 4 weeks of LHTL (>20 
h·day-1) at 2500 m altitude led to an increase in RBC and maximal oxygen consumption 
(V̇O2max), and improved running performance (5000 m time trial) in comparison to a control 
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group. In a subsequent article by the same research group, the authors showed retrospectively 
that those athletes who had a performance enhancement after LHTL (greater than the mean 
change) also demonstrated an increased plasma EPO concentration after 30 hours at altitude, 
which was elevated up to 14 days later when compared to those athletes who had no 
performance increase (11). The authors concluded that an improved erythropoietic response 
after an LHTL is the primary mediator for positive effects on performance at sea level (58). 
 
Figure 2. Schematic representation of the hematological and non-hematological adaptations following 
hypoxic exposure. See text for details. HH = hypobaric hypoxia; NH = normobaric hypoxia; PB = barometric 
pressure; FiO2 = inspired fraction of oxygen; PiO2 = inspired pressure of oxygen; PaO2 = arterial pressure of oxygen; 
SaO2 = arterial oxygen saturation; HIF-1 = hypoxia-inducible factor 1; EPO = erythropoietin; RBC = red blood 
cells; Hbmass = hemoglobin mass; V̇O2max = maximal oxygen uptake; VEGF = vascular endothelial growth factor; 
NO = nitric oxide; m=buffer capacity. 
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Recently, a meta-analysis of altitude training studies (40) has calculated that an increase in 
Hbmass of approximately 1.1% per 100 h of hypoxic exposure at ≥2100 m can be expected. 
Furthermore, the linear relationship between Hbmass and V̇O2max under normoxic conditions is 
well established, and it has been shown that a 1 g increase in Hbmass results in a ~4 mL·min-1 
rise in V̇O2max (90). However, not all altitude training studies have demonstrated an increase in 
Hbmass and/or red cell volume (RCV) (3, 18, 77). Therefore, it has to be considered that 
performance enhancement after altitude training may not solely depend on erythropoietic 
adaptations but also on non-hematological adaptations, such as enhanced mitochondrial 
efficacy, improved muscle pH regulation and muscle buffering capacity (34). In conclusion, it 
can be noted that hypoxic exposure causes a multitude of responses in the human body (figure 
2), but it seems possible that the increase in Hbmass post-altitude is the central factor leading to 
enhanced exercise performance. 
1.1.3. Measurement of hemoglobin mass (Hbmass) 
The determination of Hbmass in exercise science has become increasingly important in recent 
years. Hbmass measurements help researchers to evaluate the efficiency of training interventions 
(36, 89), especially altitude training methods (40), and the impact of iron supplementation (25). 
These measurements also aid in the detection of hematological manipulations (i.e., blood 
doping) in the antidoping field (72). The methods for the determination of Hbmass are based on 
the dilution principle, whereby tracers are injected into the blood circulation. Traditionally, 
radioactive tracers such as chromium 51 (51Cr) have been used and these are considered to be 
the gold standard (38, 88). However, methods with radioactive tracers are time- and cost-intense 
and associated with health concerns (38). As a result, a less-harmful method with Evans blue 
dye gained popularity in clinical settings (32), although its validity and reliability remain 
questionable (38). With the development of new multi-wavelength spectrophotometers (22) and 
the ability to measure carboxyhemoglobin (%HbCO) accurately and precisely (23), the use of 
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carbon monoxide (CO) as a tracer for determining Hbmass has been revived. The binding of CO 
to hemoglobin (Hb) has a 200–300 times higher affinity than that of oxygen (81), and CO is 
therefore a suitable tracer for labelling Hb and much less harmful than the radioactive tracers. 
The so-called CO rebreathing method which uses CO to label Hb, was first described by 
Grehant and Quinquard in 1882 and then gradually modified and improved by Thomsen et al. 
(97), Burge and Skinner (10), Schmidt and Prommer (88) and Prommer and Schmidt (71). 
Today, it is one of the most widely used methods for determining the Hbmass, since it is 
minimally invasive, not harmful (88), and enables quantification of the total Hbmass independent 
of plasma volume (83). Furthermore, the method allows for reliable Hbmass determinations from 
capillary blood samples; compared to venepuncture blood sampling, this method is less 
invasive and demands little technical effort (2). A recent meta-analysis of the common methods 
(38) demonstrated that the CO rebreathing method has a low ‘one-day’ measurement error of 
2.2% (expressed as a coefficient of variation [CV]) similar to the 51Cr labelling method (CV 
2.8%), whereas the Evans blue dye method showed a CV of 6.7%. The CO rebreathing method 
is considered to be valid and reliable to determine Hbmass in routine settings, while the Evans 
blue dye method should be used with caution and only in clinical applications (38). 
Schmidt and Prommer (88) further refined the CO rebreathing method by reducing CO 
rebreathing time (from ten to two minutes) and the number of blood samples (from eight to 
four, with capillary blood) as well as developing a new portable rebreathing spirometer. This 
method is also known as the “optimized CO rebreathing method” and is one of the most 
accurate techniques to determine total Hbmass with a mean ‘one-day’ typical error of 
approximately 2% (40) that enables the identification of small changes in Hbmass. CO 
rebreathing methods have been criticized for overestimating Hbmass due to the loss of CO to 
extravascular compartments, such as myoglobin (Mb) (87). Prommer and Schmidt (71) showed 
that only a small amount of CO is lost from the vascular space (0.24 mL·min-1) in the optimized 
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CO rebreathing method, resulting in an overestimation in Hbmass of 2%. Thus, the authors 
recommended the inclusion of a correction for CO flux to Mb (0.3% of administered CO per 
minute) into the calculation for total Hbmass. Nevertheless, cautious use of the optimized CO 
rebreathing method is recommended, since multiple factors can influence the measurement 
error, such as the dose of administered CO (99), replicate measures of %HbCO (1), and/or CO 
leaks (83). In summary, the optimized CO rebreathing method allows valid and reliable 
determination of Hbmass in an efficient and athlete-friendly routine procedure. 
The determination of Hbmass using the optimized CO rebreathing method is based on the change 
in %HbCO (Δ%HbCO) from before to after rebreathing a known volume of CO (88). Baseline 
%HbCO concentration is determined in the capillary blood, before a given individual CO bolus 
along with oxygen is rebreathed for two minutes within a closed circuit. It is assumed during 
the optimized CO rebreathing method that the CO should be equally distributed throughout the 
vascular system after six to eight minutes (9, 88). Therefore, at six and eight minutes after the 
inhalation of the bolus, capillary %HbCO is determined again and averaged to get the seven-
minute post-%HbCO value. In addition, the amount of CO that has not been taken up during 
the rebreathing period must be accounted for, such as the remaining CO in the spirometer and 
the CO lost via exhalation and/or diffusion to Mb. The total Hbmass is calculated using the 
formula below, described in detail by Schmidt and Prommer (88), and completed with a factor 
for CO flux to Mb presented by Prommer und Schmidt (71): 
Hbmass (g) = k × MCO × 100/(Δ%HbCO × 1.39) 
k = PB/(760 × (1 + (0.00369 × T))), PB in mbar and T is temperature in ºC; MCO = COadmin – (COsystem + COexhalation) 
– VCOMb, COadmin is the CO volume administered into the system in mL, COsystem + COexhalation is the CO volume 
not bound to hemoglobin in mL, VCOMb is the CO volume diffused to Mb (0.3% × min-1 of administered CO); 
Δ%HbCO = difference between baseline %HbCO and %HbCO after rebreathing; 1.39 = Hüfner’s number (1 g Hb 
binds 1.39 mL CO). 
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The CO dose administered during the optimized CO rebreathing method can be classified as 
low and safe (88). The CO dose can elicit Δ%HbCO ranging from 3.5% to 8.2% (99), which is 
below the CO toxicity level (>15 %HbCO) and thus not harmful to health. The half-life of CO 
in the bloodstream after completing the optimized CO rebreathing method is approximately 2 
hours, and baseline %HbCO can be reached after six hours (88). However, since the inhalation 
of CO temporarily affects an athlete’s performance (V̇O2max decrease by 3%), a time lag of >12 
hours between measurements and competition is recommended (88). Taking these conditions 
into account, the optimized CO rebreathing method allows for the evaluation of Hbmass 
adaptations to altitude training. 
1.2. Hemoglobin mass response to normobaric and hypobaric hypoxia 
1.2.1. Normobaric versus hypobaric hypoxia 
It is still debated whether NH and HH cause similar performance and physiological responses 
and thus can be used interchangeably (16, 66). The relevant difference between these two types 
of hypoxia is that NH is achieved by a reduction in FiO2 (<20.9%), and HH is achieved by a 
decline in PB (<760 mmHg) while inducing the same PiO2 (<150 mmHg) (15, 86). Thus far, it 
has been assumed that a decrease in PiO2, independently caused by a decline in PB or FiO2, will 
evoke the same physiological responses (15). This assumption is called the “equivalent air 
altitude” (EAA) model, which is an isoPiO2 model wherein PiO2 is calculated by subtracting 
the partial pressure of water vapor (47 mmHg at 37°C) from PB and multiplying by FiO2: PiO2 
= (PB–47) × FiO2 (15). However, it has been claimed that the EAA model is inaccurate and that 
HH and NH are not equal even for the same PiO2 (14, 15).  
A recent review by Coppel et al. (16) of the physiological effects of HH versus NH and a series 
of point-counterpoint discussions (66) revived the debate about Conkin’s critique of the EAA 
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model. Research on the direct comparison between HH and NH has focused only on short-term 
exposure, between 5 minutes and 26 hours (16, 84). Studies reported significant differences 
between HH and NH on physiological and performance responses when using altitudes from 
17007620 m (figure 3). The majority of the research investigated parameters related to 
ventilation and oxygenation. A reduced minute ventilation in HH was seen, accompanied with 
smaller tidal volumes, whereas inconsistent results for breathing frequency were reported (19, 
61, 86). Therefore, it has been suggested that HH induces greater dead space ventilation, 
possibly associated with the reduced PB (61, 86). Furthermore, HH resulted in lower SaO2 and 
pulse oxygen saturation (SpO2) at rest (86) and during a cycling time trial (84). It is argued that 
under HH, the PB changes might modify fluid circulation and alveoli-capillary membrane flux, 
leading to greater pulmonary vasoconstriction, and modify oxygen diffusion by decreasing the 
alveoli-capillary pressure gradient (15, 55). Under hypoxic conditions, oxidative stress is 
increased; recently, Faiss et al. (19) have shown that 24 hours of exposure in HH (3000 m, PB 
530 mmHg) exaggerated certain markers of oxidative stress more than in NH (FiO2 14.7%). In 
this study, they also demonstrated an impaired NO bioavailability and lower plasma pH level 
in HH compared to NH. The authors concluded that the different response in NO bioavailability 
and oxidative stress could explain the lower ventilatory response in HH. Lastly, acute mountain 
sickness (AMS) symptoms were higher (62) and postural control was decreased (17) in HH 
compared to NH. Taken together, these differences suggest that HH is a more stressful stimulus 
to the human body than NH, but the performance parameter is the most important from an 
athlete’s perspective. 
Only two studies have compared endurance performance (cycling time trial) after short-term 
exposure (4 to 26 h) to HH versus NH (3450 m and 4300 m) (4, 84). Both studies demonstrated 
that endurance performance impairment was greater in HH. Furthermore, the study by Saugy 
et al. (84) found lower electromyographic signals (EMG) in the vastus lateralis in HH versus 
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NH. In contrast, HH improved power and velocity performance (Pmax and 1 RM) to a greater 
extent when performing a force-velocity curve on a bench press (21). Nevertheless, the practical 
meaning of these differences for an athlete’s training is still unclear, since no studies exist that 
present a direct comparison of long-term exposure to NH and HH. Specifically, the impact of 
NH versus HH on Hbmass changes is unknown. To date, no study has directly compared LHTL 
camps in NH versus HH in terms of the effects on Hbmass and performance responses in 
endurance athletes. Therefore, we designed a randomized matched controlled study (article I) 
and a same-subject crossover study (article II) over a period of one year. 
 
Figure 3. Summary of main physiological and performance differences of hypobaric hypoxia (HH) versus 
normobaric hypoxia (NH) after short-term exposure. PiO2 = inspired pressure of oxygen; SaO2 = arterial oxygen 
saturation; SpO2 = pulse oxygen saturation; NO = nitric oxide; AMS = acute mountain sickness, Pmax = maximum 
power; 1 RM = one-repetition maximum. 
1.2.2. Individual hemoglobin mass response to altitude training 
Individual variability in an athlete’s response to altitude training has been previously discussed 
(11, 24, 57). Chapman et al. (11) demonstrated that after 4 weeks LHTL (>20 h·day-1) at 2500 
m altitude, a remarkable inter-individual variability was evident in the effect of the altitude stay 
 24 
on sea-level running performance. Retrospectively, the authors showed that those athletes who 
had an increased sea-level performance also experienced an enhanced erythropoietic response 
during altitude training (11). It was concluded that the variability in performance after an 
altitude training camp might be due to an individual’s acute increase in EPO, sufficient to evoke 
a gain in RCV. Further studies (24, 28, 70, 93, 100) have indicated wide individual variations 
in Hbmass response to different altitude training methods, although the correlation between the 
acute EPO increase during altitude and the change in Hbmass after altitude could not always be 
confirmed (24, 100). 
The reason for the inter-individual variability in Hbmass response to altitude training is still 
uncertain and may be related to several factors (see table 1). In addition to the aforementioned 
individual EPO response to altitude exposure (11, 31), it is suggested that genetic factors (i.e., 
the transcriptional mechanism of EPO gene expression [HIF-1]) may be responsible (31, 51, 
107). In this context, another hypothesis is the occurrence of a mild neocytolysis (the hemolysis 
of young RBC) (74) in some athletes after descending from altitude (24). Others have proposed 
that different baseline conditions of the athletes, such as the individual’s fitness level, health 
conditions (26, 79, 100), or insufficient iron stores (30, 95), could be responsible for the 
variation in Hbmass response. Subject variables during altitude training, such as 
psychosociological concerns (e.g., leaving family or training environment), fatigue recovery, 
or stress level might also impair individual’s Hbmass adaptations (26, 33, 46, 79). Furthermore, 
studies demonstrated that body weight loss or health conditions (inflammation, illness, or 
injury) during altitude camps can suppress the erythropoietic response (26, 41, 63, 100). It is 
supposed that a catabolic state (a mismatch between energy intake and energy expenditure) or 
an increase in proinflammatory cytokines may impair erythropoiesis (63). In this regard, an iron 
supplementation strategy during altitude training (the maintenance of iron balance and 
enhancement of iron absorption, which in turn supports erythropoiesis) is also discussed (30, 
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43). Recently, it was demonstrated that athletes who used a daily iron supplement during 
moderate altitude exposure (mean: 3000 m and 21 days) increased their Hbmass to a greater 
extent (~34%) than athletes who did not (~1.8%), particularly in athletes with low initial 
ferritin values. Lastly, it has also been suggested that the variability in individual Hbmass 
response relies on the individual’s initial Hbmass level before embarking upon the altitude 
training camp; this argument proposes that athletes with a high initial Hbmass have a limited 
ability to further increase their Hbmass after altitude training (35, 63, 76). 
Table 1 Summary of factors that might drive individual variability in hemoglobin mass (Hbmass) 
response to altitude training. 
Factors before altitude training Factors during altitude training 
 Genetic predisposition or determinants 
(31, 51, 107) 
 Increase in EPO response to hypoxia 
(11, 31) 
 Individual’s baseline Hbmass (g·kg-1) 
(35, 63, 76) 
 Fatigue recovery or stress level 
(26, 46, 79) 
 Individual’s fitness level or health  
(26, 79, 100) 
 Health condition or body weight loss 
(26, 41, 63, 100) 
 Individual’s initial ferritin level 
(30, 95) 
 Ferritin status and supplementation 
(30, 43) 
 Psychosociological concerns 
(33) 
Given the diverse sources of inter-individual Hbmass variation in the response to altitude 
training, the individual evaluation of altitude training camps should be considered. This is 
particularly applicable for elite athletes, who are trying to maximize their individual 
performance and for whom even a small increase in Hbmass (e.g., 1%) could be worthwhile for 
performance enhancement (27). Thus, it is important to improve the accuracy of individual 
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Hbmass measures for altitude training. The optimized CO rebreathing method is a reliable tool 
for determining Hbmass in athletes, with a measurement error of approximately 2% (40). The 
measurement error can be further minimized by averaging duplicate Hbmass measurements in a 
close time series (time lag < 24 h) (28, 68), which reduces the measurement error by a factor of 
√2 (30%) (47). Consequently, to more precisely identify individual Hbmass responses to altitude 
training camps, duplicate Hbmass measurements before and after an altitude intervention are 
recommended (28, 68).  
As the accuracy of Hbmass measures to altitude training, the quantification of individual Hbmass 
responses to altitude training per se is an important aspect. Studies have generally reported only 
the range of individual Hbmass values after an altitude training intervention (24, 28, 70, 93, 100). 
Since the measured variation in Hbmass responses includes both the biological and technical 
variations (1), the biological variation can be quantified by withdrawing the technical variation 
from the total variation. One possibility to quantify individual biological Hbmass variation in 
response to an intervention free of technical noise is the calculation of “individual 
responsiveness” according to Hopkins (47). The individual responsiveness can be expressed as 
the SD from the mean change and is calculated as the square root of the difference between the 
variance of the changes in the intervention group (SDdiff exp.)2 and the variance of the changes 
in the control group (SDdiff con.)2. It can be also calculated via TE: √((SDdiff exp.)2 – (TE·√2)2) 
(47). Few extant altitude training studies (63, 64, 69, 78-80) have quantified individual Hbmass 
responses to altitude interventions (details see, table 2). In summary, the abovementioned 
studies demonstrated an individual Hbmass responsiveness (i.e., individual variation free of 
technical noise) of ±1.3% to ±2.6% in HH and ±1.4% to ±2.9% in NH. 
As presented above, a wide variability in individual Hbmass response to altitude training has 
been shown, and several factors might be responsible. To quantify the individual variation more 
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precisely and provide further insights into individual Hbmass response to altitude training, we 
therefore implemented duplicate Hbmass measures, quantified individual responsiveness 
according to Hopkins (47), and created a same-subject crossover design (articles I and II). 
Furthermore, since altitude training is primarily used by elite endurance athletes, who typically 
present elevated Hbmass values, we tested the hypothesis that athletes embarking on an LHTL 
camp with a high initial Hbmass have a limited ability to further increase their Hbmass post-
intervention with a direct comparison study design using individual data and matched hypoxic 
dose (article III). 
1.2.3. Aims of the thesis 
Article I: To compare Hbmass and performance changes during an 18-day LHTL altitude 
training camp between NH and HH using a randomized matched controlled study design. 
Article II: To investigate whether Hbmass responses differ between an 18-day LHTL altitude 
training camp in NH or HH using a same-subject crossover design. The study also focused on 
the quantification of individual Hbmass responsiveness to NH and HH. 
Article III: To examine the relationship between initial Hbmass prior to LHTL (absolute and 
relative values) and percentage Hbmass increase following LHTL camps with comparable 
hypoxic doses in male endurance and team-sport athletes. 
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Table 2 Summary of current research calculating individual hemoglobin mass response to altitude training, according to Hopkins (47). 
Author n Sex Sport Level Training 
mode 
Hypoxic 
mode 
Duration Altitude Hypoxic 
dose 
Hypoxic 
dose 
Typical 
error 
Mean Hbmass 
change 
Individual 
response* 
       (day) (meter) (hours) (km.h) (%) (%)  
Troesch et al. 
(98) 
7 m Running Elite LHTH HH 20 1800 480 864 1.8 +1.6 ±1.5% 
McLean et al. 
(63, 64) 
21
23 
m Australian 
Football 
National LHTH 
LHTH 
HH 
HH 
19  
18  
2100 
2130 
456 
432 
958 
920 
2.6 +3.6 
+4.0 
±1.3% 
±2.2% 
Neya et al. 
(69) 
7 m Running Collegiate LHTL+ 
TM 
NH 
HH 
21  3000 
<1800 
210 630 2.4 +2.1 ±2.9% 
Robertson et al. 
(78) 
9 m Swimming Elite LHTL 
LHTL+ 
LMTM 
NH 
NH + 
HH 
2 x 10 
2 x 10 
2600 
2600 
1350 
 
̴ 190 
̴ 95 
240 
494 
571 
1.2 +0.9 (mean) 
LHTL 1+3: <0.7
LHTL 2+4: <2.3 
±2.6% 
Robertson et al.  
(79) 
8 m, f Running Highly 
trained 
2 x LHTL NH 21 3000 294 882 2.0 +2.8 (camp 1) 
+2.7 (camp 2) 
±2.4% 
±1.4% 
Robertson et al. 
(80) 
8 m, f Running Well  
trained 
LHTL+ 
TH 
NH 
NH 
21 3000 
2200 
294 
̴ 14 
913 1.8 +3.6  ±2% 
*i.e. the individual variation in the response to an intervention free of typical error.  
Hbmass = hemoglobin mass, HH = hypobaric hypoxia, NH = normobaric hypoxia, LHTH = live high–train high, LHTL = live high–train low, LMTM = live moderate–train 
moderate, TM = train moderate, TH = train high
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2. Summary of experimental results 
2.1 Article I: Hemoglobin mass response in normobaric versus hypobaric 
hypoxia  
Using a randomized matched controlled study design, we compared Hbmass response after the 
same hypoxic dose (approximately 230 h) and after the same duration (18 days) for groups in 
normobaric (NH; n = 10) and hypobaric (HH; n = 11) LHTL training camps as well as a control 
group (CON; n = 7), for the first time. 
Hbmass increased similarly in the HH (+4.4%, P < 0.001 at day 13; +4.5%, P < 0.001 at day 18) 
and NH (+4.1%, P < 0.001) groups compared to CON (+1.9%, P = 0.08). The likelihood of 
%Hbmass changes in the altitude groups was likely beneficial compared to CON (>79% 
positive), with an unclear effect (>50% trivial) between the HH and NH groups after the same 
hypoxic dose and after 18 days. There was a wide variability in individual Hbmass responses in 
the HH (–0.1 to +10.6%) and NH (–1.4 to +7.7%) groups. Lastly, after hypoxic exposure, a 
decrease in EPO was observed in the HH (d = 1.9, P < 0.001, –39.4%) and NH (d = 1.6, P < 
0.001, –51.3%) groups compared to the CON (d = 0.3, P = 0.48, –8.4%) group. 
Post-test running time decreased in the HH (-3.9%, P < 0.001), NH (-3.3%, P < 0.001), and 
CON (–2.1%, P = 0.03) groups, whereas cycling performance changed non-significantly in the 
HH and NH (+2.4%, P > 0.08) groups and remained unchanged in CON (+0.2%, P = 0.89). The 
performance gains in the altitude groups were likely higher compared to the CON group (>64% 
positive), with an unclear effect (>39% trivial) between the HH and NH groups. There was a 
large correlation between the percent changes in relative Hbmass (g·kg-1) and 3-km running time 
from pre- to post-test in the altitude groups (r = -0.64, P < 0.001). 
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2.2 Article II: Individual Hbmass responses in normobaric and hypobaric 
LHTL 
To have a higher statistical power and to compare mean and individual Hbmass responses 
following 18 days in normobaric and hypobaric LHTL, a same-subject crossover study design 
(n = 15) was applied. 
After 18 days, Hbmass increased similarly in the HH (916 to 957 g, 4.5 ± 2.2%, P < 0.001) and 
NH (918 to 953 g, 3.8 ± 2.6%, P < 0.001) groups, and changes did not differ between the two 
groups (P = 0.42). The chance of the percent Hbmass changes being greater in the HH group 
compared to the NH group was 36%. The percent changes in individual Hbmass ranged from 
+0.4% to +8.7% in the HH group and from –1.4% to +7.7% in the NH group after an 18-day 
LHTL camp. The 95% confidence limits (CLs) for individual percent Hbmass changes was ± 
3.9%, and the upper CL was exceeded by eight out of 15 athletes in HH and seven out of 15 
athletes in NH. Individual responsiveness (i.e., individual variation in response to an 
intervention free of technical noise) was ±0.9% in the HH group and ±1.7% in the NH group. 
There was a correlation between intra-individual delta Hbmass changes (by percentage) in HH 
and NH (r = 0.52, P = 0.048). 
Lastly, all athletes had initial ferritin levels of >30 µg·L–1 and were within the cut-off limits for 
the OFF scores (< 125.3, (39)) in the HH and NH groups both pre-test (91.7 ± 5.4 vs. 94.6 ± 
14.1, respectively) and post-test (97.2 ± 6.3 vs. 97.9 ± 5.1, respectively). No differences were 
found in daily average training loads between the two groups (HH: 217.6 ± 87.9 ECOs and NH: 
229. ± 80.0 ECOs) during the training camps of the crossover study (P = 0.54). 
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2.3 Article III: Relationship between initial Hbmass and Hbmass response 
following LHTL in athletes 
To test the hypothesis that athletes embarking on an LHTL camp with a high initial Hbmass have 
a limited ability to further increase their Hbmass post-intervention, a data set of 58 male athletes 
was analyzed. This is the first study to evaluate this hypothesis by using individual data and 
strict methodological control (duplicate Hbmass measures and matched hypoxic dose). 
While there was no relationship (r = 0.02, P = 0.91) between absolute initial Hbmass (g) and 
percent absolute Hbmass increase, a moderate relationship (r = -0.31, P = 0.02) was detected 
between initial relative Hbmass (g·kg-1) and percent relative Hbmass increase. Mean absolute and 
relative Hbmass increased to a similar extent (P ≥ 0.81) in athletes partaking in endurance (from 
916 ± 88 to 951 ± 96 g, +3.8%, P < 0.001 and from 13.1 ± 1.2 to 13.6 ± 1.1 g·kg-1, +4.1%, P < 
0.001, respectively) and team (from 920 ± 120 to 957± 127 g, +4.0%, P < 0.001 and from 11.9 
± 0.9 to 12.3 ± 0.9 g·kg-1, +4.0%, P < 0.001, respectively) sports following LHTL. Furthermore, 
there was no relationship (r = -0.006, P = 0.96) between individual percent changes in body 
weight and absolute Hbmass. A large inverse relationship (r = -0.64, P = 0.002) occurred between 
individual percent changes in body weight and relative Hbmass. 
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3 Discussion and perspectives 
3.1 Discussion 
3.1.1. Hemoglobin mass responses in normobaric versus hypobaric LHTL 
The present thesis provides new insights about Hbmass responses to hypobaric versus 
normobaric LHTL in endurance athletes with a special focus on inter-individual variability in 
Hbmass response to altitude exposure. There has been no previous direct comparison of Hbmass 
response to NH and HH using a randomized matched controlled study design (article I) and a 
crossover study design (article II). The main findings indicate that HH and NH evoked a similar 
mean increase in Hbmass following an 18-day LHTL camp, despite a larger hypoxic dose in HH 
compared to NH. 
The observed mean Hbmass increases of 4.4% and 4.5% in HH and 4.1% and 3.8% in NH after 
18 days of LHTL in articles I and II, respectively, were of greater magnitude than in LHTL 
studies with similar total hypoxic hours (13, 49, 77). Furthermore, despite greater total hours 
of hypoxic exposure in HH (approximately 315 h) compared to NH (approximately 230 h), the 
mean Hbmass response was similar. Recently, a meta-analysis by Gore at al. (40) estimated that 
Hbmass increases by ~1% per 100 h of NH or HH exposure (>2000 m), which would mean lower 
averaged Hbmass responses (~1% to 2%) in NH but also in HH. However, Hbmass response to 
altitude depends on inter-individual variability, and in the specified meta-analysis, the 
calculated “upper 95% individual response limits” for ~230 h and ~315 h were around 5% and 
6%, respectively, suggesting that group composition can noticeably influence the mean Hbmass 
response to altitude exposure. The nature of natural altitude means that athletes in HH 
accumulated hypoxic hours much faster than in NH (17 h·day-1 vs 13 h·day-1). Therefore, to 
compare matched hypoxic hours in HH and NH (approximately 230 h), an additional duplicate 
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Hbmass measurement was performed during the second training camp at day 13 in the HH group 
(hypoxic dose matched to 18-day NH, article I). In addition, a similar mean Hbmass response 
between the HH and NH groups was found for matched hypoxic hours. More interesting, there 
was no additional increase from day 13 to day 18 in the HH groups despite a larger number of 
hypoxic hours after an 18-day LHTL camp (230 vs. 315 h). This lack of increase could be 
attributed to individual variability in the time course of Hbmass response to altitude (13, 28) or 
still be due to measurement error. Overall, the detected Hbmass increase after 230 h and after 13 
days is in line with previous studies (28, 29, 69, 100) that show measurable Hbmass increases 
(2.1% to 3.7%) within a shorter time period (11–13 d) or lower total hypoxic exposure (<210 
h) than previously recommended (>12 h·day-1 for at least 21 days) (82). Therefore, the present 
thesis assumes that Hbmass adaptations can be achieved with fewer hypoxic hours in some 
subjects. 
Whether a hypoxia-induced increase in Hbmass is the primary physiological mechanism leading 
to enhanced sea-level performance following LHTL is still under discussion (37, 50, 58, 106). 
The present thesis demonstrated a correlation between the percent changes in relative Hbmass 
(g·kg- 1) and 3-km running time for the HH and NH groups (r = -0.64, P = 0.002), suggesting 
that the enhancement of endurance performance was primarily mediated by an increase in 
Hbmass. However, due to the multifactorial adaptation mechanisms in hypoxia, the enhancement 
in endurance performance cannot be attributed solely to one parameter. Thus, non-
hematological mechanisms, such as improved mitochondrial efficiency and/or muscle pH 
regulation, might also contribute to enhanced sea-level performance following altitude 
exposure (34). 
Thus far, short-term exposure (<26 h) to HH seems to be a more stressful stimulus to the human 
body than NH (16, 66). The present thesis indicated that long-term exposure (i.e., 18-day LHTL 
camp) at 2250 m to HH and NH induced similar Hbmass responses using a randomized matched 
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controlled study design and a crossover study design. Furthermore, running and cycling 
performance changes as well as blood parameters did not differ between the HH and NH groups 
after the 18-day LHTL training camp (figure 4). To date, only a meta-analysis (7) has indirectly 
compared the effects of hypobaric versus normobaric LHTL on endurance performance, 
demonstrating that hypobaric LHTL was more beneficial compared to normobaric LHTL 
(+4.2% vs. +1.4%) in sub-elite athletes. Nevertheless, the present data indicate that chronic 
LHTL exposure to HH or NH over a period of >13 days at moderate altitude results in no 
substantial differences in performance and physiological responses, suggesting that HH and 
NH can be used interchangeably for LHTL camps in endurance athletes. 
 
Figure 4. Extension of figure 3 (see chapter 1.2.1)  Summary of main physiological and performance 
differences of hypobaric hypoxia (HH) versus normobaric hypoxia (NH) after short- and long-term 
exposure. LHTL = live high–train low; Hbmass = hemoglobin mass; RBC = red blood cells; Hb = hemoglobin; Hct 
= hematocrit; EPO = erythropoietin; Pmax = maximal power 
3.1.2. Individual hemoglobin mass response to altitude training 
The present thesis confirmed the previously recognized variability in individual Hbmass response 
to altitude training in athletes (11, 24, 28, 100). To enhance the methodological control in all 
studies, duplicate Hbmass measures were applied, and a same-subject crossover design (article 
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II) was used in one study. Furthermore, to quantify individual responses or to detect significant 
individual effects, statistical approaches were applied according to Hopkins (47, 48). Overall, 
a notable inter-individual variability in Hbmass response to HH and NH in endurance and team-
sport athletes was shown, which was not attributed to the initial Hbmass value or ferritin stores 
prior altitude exposure. 
The absolute range in percent changes in individual Hbmass responses after 18 days of LHTL 
was –0.1 to +10.6% for the HH groups and–1.4 to +7.7% for the NH groups (articles I and II). 
To detect significant individual effects, the 95% CLs for percent changes of Hbmass were derived 
from the present TE of the Hbmass measurement (95% CL = ± 1.96 TE · √2 · 1/√2) (47). The 
upper 95% CL (± 3.7% and ± 3.9%) for %Hbmass was exceeded by more than half the athletes 
in the HH and the NH groups. Because we applied duplicate Hbmass measures at each time point, 
which enhances the measurement precision, it can be assumed that those athletes who exceeded 
the upper CL were very likely “Hbmass responders” to 18-days of LHTL training at 2250 m in 
either the HH or NH groups. In addition to the statistical significance, all athletes demonstrated 
normal initial ferritin values (Ftn >30 µgL–1) (42) without doping abuse (doping control scores 
within normal ranges (85)) or different daily training loads during the altitude stay, which 
further supported the beneficial effect of an 18-day LHTL camp on Hbmass. Since the absolute 
range of percent changes in individual Hbmass is limited to quantify the extent of individual 
responsiveness, we used the Hopkins approach (47), where the magnitude of individual 
responses can be expressed as the SD from the mean change. In the present thesis, the 
magnitude of individual responsiveness was ±0.9% in the HH group and ±1.7% in NH group 
after an 18-day LHTL camp (article II), which was slightly lower than in other studies that 
report individual Hbmass responsiveness of ±1.3% to ±2.6% in HH (63, 78) and ±1.4% to ±2.9% 
in NH (69, 79). For details, see table 2. These studies were primarily based on single measures 
of Hbmass with the optimized CO rebreathing method, suggesting that duplicate measures of 
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Hbmass, which reduces the TE by a factor of 1/√2 (47), diminish the inter-individual variability 
in Hbmass response to altitude training. Whether individual Hbmass responses to altitude training 
are reproducible is still unclear. In the crossover study design (article II) many of the athletes 
demonstrated a reproducible Hbmass response after the second LHTL camp (r = 0.52, P = 0.048), 
suggesting that those athletes who responded once to altitude training will likely respond 
another time regardless of the type of hypoxia. This result is not in line with previously 
published studies that focus on the reproducibility of Hbmass responses in athletes to altitude 
training camps (63, 100) and that demonstrate reproducible mean percent Hbmass changes but 
only a small trend toward reproducible individual Hbmass changes. Therefore, further research 
on the reproducibility and quantification of the magnitude of individual Hbmass responses is 
needed. 
The reason for individual variability in Hbmass response to altitude training is still unknown and 
may be related to several factors (see table 1). It has been suggested that initial low iron stores 
may impair Hbmass production and thus reduce the effectiveness of altitude training (95). 
Articles I and II demonstrated a small (r = 0.3, P = 0.095) and inverse (r = -0.30, P = 0.10) 
correlation between the pre-altitude ferritin level and Hbmass (in g) changes, suggesting that in 
the present thesis, pre-altitude ferritin levels did not influence individual variability in Hbmass 
responses. However, the possibility cannot be ruled out that higher pre-altitude ferritin levels 
or individualized iron supplementation during altitude training would have supported Hbmass 
production (30). A further reason for this individual variation in Hbmass response could be an 
individual’s baseline Hbmass level prior to altitude training. It is supposed that athletes starting 
with high initial Hbmass levels have a limited ability to further increase their Hbmass following 
altitude training because those athletes would already have maximized their Hbmass level by 
training at sea level (63, 76). Since altitude training is primarily used by elite endurance athletes 
who typically already have elevated Hbmass values, this hypothesis is important to the relevance 
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of altitude training in elite athletes. A recent analysis of nine LHTL studies in endurance 
athletes (76) and a classic altitude training study on Australian footballers (63) demonstrated 
significant correlations (r = -0.86, P < 0.01 and r = -0.51, P = 0.04) between initial relative 
Hbmass and post-altitude percentage increase in relative Hbmass. By contrast, the present thesis 
(article III) showed a trivial (r = 0.02, absolute values) and moderate (r = -0.31, relative values) 
correlation between initial Hbmass and percentage Hbmass increase following LHTL in endurance 
and team-sport athletes. Because we used strict methodological control (duplicate Hbmass 
measures, matched hypoxic dose, and different athlete populations), it can be concluded that 
even athletes with elevated pre-altitude Hbmass levels can benefit from LHTL camps. The 
moderate relationship between initial relative Hbmass and percent change in Hbmass following 
the LHTL camp could be attributed to the individual changes in body weight before and after 
the LHTL camp because there was an inverse relationship (r = -0.64) between individual 
percent changes in body weight and relative Hbmass, whereas no relationship between individual 
percent changes in body weight and absolute Hbmass appeared. Therefore, both absolute and 
relative Hbmass values should be evaluated after altitude camps to assess the sole effect of initial 
Hbmass on Hbmass response to altitude and exclude the confounding factor “body weight 
changes”. Furthermore, for future comparisons, it seems that relative Hbmass values adjusted for 
lean body mass would be a better unit.  
3.1.3. Limitations 
In articles I and II, it was important to compare two common real-world LHTL training 
practices performed by endurance athletes (e.g., daily hypoxic exposure under NH and HH, 
with the same training loads and recovery time). Therefore, the stated total (315 h vs. 230 h) 
and daily (17 h vs. 13 h) hypoxic exposures were higher in the HH groups compared to the NH 
groups, which is in accordance with previously published LHTL studies (7, 40). The difference 
in daily hypoxic exposures can be explained by a faster accumulation of hypoxic hours in HH 
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than in NH. Under HH conditions, athletes lived continuously in a hypoxic environment except 
during the training times, whereas under NH conditions, athletes accumulated hypoxic hours 
only during their stays in the hypoxic rooms (sleep and recovery times). To directly compare 
the same hypoxic hours (approximately 230 h) between the two conditions, we performed an 
additional Hbmass measurement in the HH group at day 13 of the second training camp (see 
article II crossover design). However, the possibility that the unequal nature of the daily 
hypoxic dose in HH and NH could have influenced the Hbmass responses cannot be excluded. 
It was argued that endurance training rather than the hypoxic stimulus was responsible for the 
increase in Hbmass response in the LHTL groups (92), since the rate of Hbmass in the HH group 
at day 13 and in the NH group at day 18 was too high compared to typical altitude training 
responses (73). However, individual variability in Hbmass response to altitude training exists, so 
the group compositions could have notably influenced the mean Hbmass responses (101). 
Furthermore, all measured mean Hbmass responses (3.84.5%) for the present thesis were within 
the upper 95% CL calculated by the meta-analysis by Gore (40). Nevertheless, even with 
duplicate Hbmass measurements, there is still the possibility of random noise (40). 
Altitude training studies with athlete populations often have small sample sizes (~10 subjects) 
and thus have a low statistical power, as in articles I and II. Therefore, in addition to the 
conventional statistical approach, we used a contemporary statistical approach recommended 
by Hopkins (11), which defines the chances that the “true” value of an effect is practically 
relevant. Lastly, in article III, despite a large sample size (n = 58), it seems that part of the 
inverse relationship between initial relative Hbmass and percent changes in relative Hbmass after 
the LHTL camp could be attributed to the statistical phenomenon “regression to the mean”. 
Thus, when evaluating the relationship between changes and initial values, the statistical 
phenomon regression to the mean must be taken into account (6).  
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3.2 Overall conclusion and perspectives 
The present thesis indicated that hypobaric and normobaric LHTL evoked similar mean 
increases in Hbmass as well as similar performance changes after an 18-day LHTL camp. Among 
the Hbmass changes, there was a notable variation in individual Hbmass response, which tended 
to be reproducible. The individual variability in Hbmass response to LHTL training camps was 
not reliant on the individual’s initial Hbmass level before embarking upon the altitude training 
camp. It was found that the moderate relationship between initial relative Hbmass and percent 
change in relative Hbmass following LHTL in the present thesis could be attributed to changes 
in body weight and possibly to the statistical phenomenon regression to the mean, rather than 
to a pure physiological effect. Lastly, the present thesis indicated that Hbmass adaptations can be 
achieved with fewer hypoxic hours in some subjects than was previously hypothesized. 
From a practical point of view, it can be assumed that both hypoxic conditions can be used 
interchangeably for a LHTL training camp to obtain beneficial effects on Hbmass and endurance 
performance. However, both hypoxic conditions do have specific benefits and drawbacks. 
While an athlete under HH accumulates hypoxic hours much faster, HH is logistically more 
difficult (e.g., the travel effort from high to low altitude). In contrast, NH is more convenient 
and enables the individualization of the hypoxic stimulus for the athletes, but they require more 
time to accumulate sufficient hypoxic doses and living in hypoxic rooms or tents might be more 
uncomfortable. The variability in individual Hbmass response to altitude training in the present 
thesis emphasizes the importance of individual Hbmass evaluation for altitude training in 
athletes. To enhance Hbmass measurement precision, we recommend error-reducing duplicate 
Hbmass measures directly before and after an altitude training camp (time lag <24 h between the 
two measurements). Overall, altitude training for elite athletes should be carefully planned and 
performed (i.e., sufficient iron status both before and during altitude, acclimatization time, 
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positive ratio of stress and recovery, and sufficient nutrition intake) to expect positive effects 
on Hbmass and performance. 
As the present thesis and the reported studies used small sample sizes and different athlete 
populations and applied different altitude protocols, further research on reproducibility and 
quantification of individual Hbmass response to HH and NH is needed. Lastly, future studies 
should also focus on genetic parameters to better understand the individual variability in Hbmass 
responses to altitude training. 
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ABSTRACT 
Purpose: To compare hemoglobin mass (Hbmass) changes during an 18-day live high-train low 
(LHTL) altitude training camp in normobaric hypoxia (NH) and hypobaric hypoxia (HH). 
Methods: Twenty-eight well-trained male triathletes were split into three groups (NH: n = 10, 
HH: n = 11, control (CON): n = 7) and participated in an 18-day LHTL camp. NH and HH slept 
at 2250 m while CON slept and all groups trained at altitudes <1200 m. Hbmass was measured 
in duplicate with the optimized CO rebreathing method before (pre-), immediately after (post- ) 
(hypoxic dose: 316 vs. 238 h for HH and NH), and at day 13 in HH (230 h, hypoxic dose 
matched to 18-day NH). Running (3-km run) and cycling (incremental cycling test) 
performances were measured pre- and post. Results: Hbmass increased similar in HH (+4.4%, 
P < 0.001 at day 13; +4.5%, P < 0.001 at day 18) and NH (+4.1%, P < 0.001) compared to CON 
(+1.9%, P = 0.08). There was a wide variability in individual Hbmass responses in HH (–0.1 to 
+10.6%) and NH (–1.4 to +7.7%). Post-running time decreased in HH (-3.9%, P < 0.001), NH 
(-3.3%, P < 0.001), and CON (–2.1%, P = 0.03), whereas cycling performance changed non-
significantly in HH and NH (+2.4%, P > 0.08) and remained unchanged in CON (+0.2%, P = 
0.89). Conclusion: HH and NH evoked similar Hbmass increases for the same hypoxic dose and 
after 18-day LHTL. The wide variability in individual Hbmass responses in HH and NH 
emphasize the importance of individual Hbmass evaluation of altitude training. 
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Introduction 
The altitude training method live high-train low (LHTL) is well accepted and frequently used 
by elite endurance athletes to improve sea-level performance (25, 27, 42). In contrast to classic 
altitude training (living and training at altitude), LHTL allows athletes to maintain exercise 
intensity and O2 flux comparable to sea-level as well as to obtain the physiological benefits of 
altitude acclimatization (20). For elite endurance athletes, the aim of LHTL is to improve their 
sea-level endurance performance, which is primarily obtained by an increase in hemoglobin 
mass (Hbmass) (14, 33). Altitude training studies have shown a significant increase in Hbmass that 
is estimated to be 1.1%/100 h of hypoxic exposure at ≥2100 m (14). There is also a large 
consensus for recommending daily exposure >12 h and a total hypoxic exposure of 
approximately 300 h to substantially increase Hbmass (7, 25, 27). Since LHTL is associated with 
time-consuming travel effort from high to low altitudes, and to provide a more logistically 
convenient environment for athletes, the original LHTL method (20) was further developed by 
using technical devices (e.g., hypoxic chambers or tents) to simulate an altitude environment 
(e.g., normobaric hypoxia using nitrogen dilution or oxygen extraction) (25, 42). 
To date, it is still debated whether normobaric hypoxia (NH) and hypobaric hypoxia (HH) 
evoke different or similar physiological responses (9, 11, 24). Short-term exposure (<24 h) to 
HH seems to lead to greater hypoxemia and lower oxygen arterial saturation (34), reduced 
ventilatory response (10, 21), and impaired nitric oxide bioavailability (10) compared to NH. 
However, the practical significance of these differences for an athlete’s preparation is still 
unclear. Particularly, the effects of NH versus HH on Hbmass changes are unknown, since no 
data on a direct comparison of long-term exposure to NH and HH with the same hypoxic dose 
exist. The latter is of particular importance, since it may influence an athlete’s altitude training 
adaptation. Only one study compared the differences between prolonged exposure to HH and 
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NH in endurance athletes during an 18-day LHTL training camp (30). In this study however, 
the HH group demonstrated a larger total hypoxic dose after the LHTL camp compared to the 
NH group (300 vs. 220 h). 
Since thus far no study has compared Hbmass changes to normobaric and hypobaric LHTL with 
the same hypoxic dose, it remains unclear for endurance athletes whether a LHTL training camp 
under normobaric or hypobaric hypoxic conditions evoke similar Hbmass responses. This study 
therefore aimed to compare (i) Hbmass changes between normobaric and hypobaric LHTL after 
the same hypoxic dose (230 h at the same altitude) and (ii) differences in Hbmass and 
performance changes after an 18-day LHTL training camp (higher hypoxic dose in HH, but 
same training load between groups) in either HH or NH in comparison to a control group 
(CON). 
 
 
Methods 
Subjects 
Twenty-eight well-trained male triathletes, living at or near sea level (age: 26 ± 5 yrs, height: 
179 ± 6 cm and body mass: 70 ± 6 kg) participated in the study. The inclusion criteria for 
participation and data analysis were as follows: 1) a minimum of 5 yrs of endurance training 
and frequent participation in endurance competitions and 2) initial ferritin levels >30 µg·l-1 (no 
iron supplementation during the study). All athletes provided written informed consent to 
participate in the study. The study was approved by the local ethical committee (N°CPP EST I: 
2014/33; Dijon, France), and all procedures were conducted in accordance with the Declaration 
of Helsinki. 
 58 
Study Design 
Within a 3-week period, all athletes completed an 18-day training camp and two testing sessions 
immediately before (pre-) and after (post-) (Figure 1). After the pre-tests, the athletes were 
assigned to one of the three training groups matched to their 3-km running time: 1) LHTL with 
normobaric hypoxic exposure (n = 10; 3-km time: 623 ± 47 s, NH), 2) LHTL with hypobaric 
hypoxic exposure (n = 11; 3-km time: 643 ± 57 s, HH), and 3) the control group (n = 7; 3-km 
time: 632 ± 59 s, CON). Both altitude groups slept at an altitude of 2250 m under either 
simulated (NH) or natural (HH) hypoxic conditions, whereas the CON group lived and all 
groups trained at altitudes <1200 m. Before the training camp, first Hbmass in duplicate and 
hematological parameters were measured, and then the performance tests (incremental cycling 
test and 3-km run) were conducted. At day 13 of the LHTL camp, an additional duplicate Hbmass 
measurement was performed in the HH group, as it corresponded to the expected hypoxic dose 
in NH after 18 days (the same hypoxic dose in the HH and NH groups). After the training camp, 
first the performance tests were performed and then the Hbmass and hematological 
measurements. All 3-km running tests were performed near sea level (390 m), whereas the other 
measurements were performed at 1150 m. During the training camp, the training load and the 
hypoxic dose were continuously recorded. 
Hypoxic Exposure 
The HH group lived at Fiescheralp, Switzerland (2250 m, inspired oxygen pressure (PiO2) 111.7 
± 0.7 mm Hg; inspired oxygen fraction (FiO2) 20.9% ± 0.0, barometric pressure (PB) 580.8 ± 
3.3 mm Hg) and traveled by cable car twice daily to the valley (altitude <1200 m) for training. 
The daily hypoxic dose in the HH group amounted 17.4 ± 1.2 h. At day 13 during the training 
camp, the total hypoxic dose in the HH group was 229.5 ± 1.3 h, and after 18 days, the dose 
was 316.4 ± 2.3 h. The NH group lived in Prémanon, France (1150 m) and was exposed to 
normobaric hypoxia equivalent to 2250 m in hypoxic rooms (medium size: 15 ± 1 m2). 
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Normobaric hypoxia was obtained by extracting oxygen from ambient air in hypoxic rooms 
(PiO2 112.7 ± 0.1 mm Hg; FiO2 18.1% ± 0.1; PB 668.2 ± 2.5 mm Hg). In each hypoxic room, 
the gas composition was continuously monitored with oxygen and carbon dioxide analyzers 
(FIELDBROOK Ltd, London, UK), which were connected to a central monitoring station under 
the control of an experienced physiologist. The NH group in Prémanon left the hypoxic rooms 
on average 5–6 times per day to eat and train. The daily hypoxic dose in the NH group was 13.1 
± 1.6 h, and the total hypoxic dose after 18 days in the NH group amounted 238.2 ± 10.6 h. For 
both groups, the time spent in hypoxia was monitored daily and recorded manually. 
 
Figure 1. Illustration of the study design in hypobaric hypoxia (HH), normobaric hypoxia (NH), or normoxia 
(CON). 
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Training Load 
All training sessions during the training camp were supervised with the volume and intensity 
matched for all groups by two experienced certified coaches. The HH and NH group trained 
separately, since they were located at two different places. The CON group lived nearby the 
NH group and trained most of the time together with the NH group. The training consisted of 
cycling, running, and swimming. Training load quantification was performed using the 
Objective Load Scale (ECOs) (4), which was specially developed for training load 
quantification in triathlon. Briefly, the ECOs were calculated by multiplying the total duration 
of a training session (time in minutes) with a scoring value between 1 and 50, depending on the 
heart rate–based training zone (1 to 8), and by a factor of 1.0, 0.75, or 0.5 for running, 
swimming, or biking, respectively. The daily training loads (ECOs) of each subject were 
measured based on each subject’s physical characteristics and training program intensity. 
Running and Cycling Performance 
Running performance was evaluated during a 3-km run performed on a 400-m outdoor synthetic 
track at sea level. Starts were individual in a time-trial form (i.e., 30 s between each start), to 
avoid group or pacing effects. Pre- and post-3-km runs were performed under equivalent 
conditions: 22 C°, PB 738.4 mm Hg, 62% humidity, and 2.5 m·s–1 wind speed and 20 C°, PB 
739.5 mm Hg, 60% humidity, and 1.9 m·s–1 wind speed for the pre- and post-runs, respectively. 
Cycling performance was assessed with the determination of the maximal aerobic power during 
an incremental cycling test on an electromagnetically braked cycle ergometer (Lode Excalibur 
Sport, Groningen, the Netherlands). After a 5-min warm-up period at a workload of 90 W, the 
workload was subsequently increased by 30 W·min–1 until voluntary exhaustion. 
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Hemoglobin Mass  
During each testing session, Hbmass was measured in duplicate by using a slightly modified 
version of the optimized carbon monoxide (CO) rebreathing method described by Schmidt and 
Prommer (35). Briefly, subjects spent 5 min in a sitting position before three capillary blood 
samples (35 µL) were taken from the earlobe and analyzed immediately for baseline 
carboxyhemoglobin (%HbCO) values (ABL 800flex, Radiometer A/S, Copenhagen, 
Denmark). Subjects then rebreathed for 2 min a gas mixture of 100 mL pure CO (Multigas SA, 
Domdidier, Switzerland) and 3.5 L oxygen in a closed circuit system (glass spirometer, Blood 
Tec GbR, Bayreuth, Germany). During the rebreathing period, a CO gas analyzer (Dräger PAC 
7000, Dräger Safety, Lübeck, Germany) was used to check for possible CO leakage at the nose, 
mouthpiece, and spirometer system. At 6 and 8 min after CO rebreathing started, two final 
capillary blood samples were taken from the earlobe and averaged as a 7-min post %HbCO 
value. Directly before and 2 min after the rebreathing, the same CO gas detector was used to 
measure the end-tidal CO concentration in parts per million. Hbmass was calculated from the 
mean change in %HbCO before and after CO rebreathing, as described previously by Steiner 
and Wehrlin (37). Both measurements were performed on two consecutive days (12- to 24-h 
time lag between the measures), and the results were averaged. In this study, the typical error 
(TE) of the CO rebreathing method was 1.9% in our mobile laboratory. Since averaged 
duplicate measurements reduce the TE by a factor of 1/√2, the TE for the averaged duplicate 
measurements was 1.3% (17). 
Blood Samples 
On the first morning in pre- and post-testing, venous blood samples were drawn from an 
antecubital vein (4.9 ML EDTA tube, Sarstedt, Nümbrecht, Germany) immediately after the 
athletes woke up (7 am). To determine red blood cells (RBC), hemoglobin (Hb), hematocrit 
(Hct), and reticulocyte percentage (Ret), blood was analyzed via fluorescent flow cytometry 
 62 
and hydrodynamic focusing (XT-2000i, Sysmex Europe, Norderstedt, Germany). The 
coefficient of variation (CV), which was determined using internal quality controls, was below 
1.5% for Hb and 15% for Ret. Plasma EPO was measured using a standard procedure with an 
enzyme-linked immunosorbent assay (ELISA) kit (Stemcell Technologies, Grenoble, France). 
CVs determined with three internal quality controls (levels: low, medium, and high) were below 
15%. Additionally, serum ferritin concentration (Ftn) was quantified using standard laboratory 
procedures (Dimension EXL, Siemens Healthcare Diagnostics SA, Zürich, Switzerland). To 
exclude the potential risk of misuse of recombinant human erythropoietin, all athletes were 
tested for doping by an accredited laboratory (Swiss Laboratory for Doping Analyses, 
Lausanne, Switzerland) according to the standards of the Athlete Biological Passport (31). All 
plasma samples were analyzed in duplicate, and the mean values were used for this study. 
Statistical Analyses 
Data are presented as mean ± standard deviation (SD). The collected data were tested for 
normality (the Shapiro-Wilk test) and equal variance. A two-way repeated measure analysis of 
variance (ANOVA) was applied to evaluate the group differences between the pre- and post-
measurements and group x time interactions. When a significant global effect was indicated, 
Tukey’s post hoc test was performed to identify significant differences between the time points 
and the groups. A linear regression was used to determine the relationship between the percent 
changes in relative Hbmass and the 3-km running time. Correlation classification of Hopkins (19) 
was used to interpret the size of the correlation. An α of P < 0.05 was considered significant. 
All analyses were processed using Sigmaplot 11.0 (Systat Software, San Jose, CA). To estimate 
the magnitude of the changes within the groups, the effect size Cohen’s d (d) was calculated 
(8), which was classified as follows: small effect d = 0.20, moderate effect d = 0.50, and large 
effect d = 0.80 (8). 
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To quantify the likelihood that the true mean of percent changes in Hbmass and performance 
parameters was relevant (i.e., more extreme than the smallest worthwhile change (SWC) of 
Hbmass and performance, set to ± 1%), a contemporary statistical approach was used (18). The 
magnitude of the change in the mean and the spreads of the 90% confidence limits (CL) were 
used to classify the effects (positive, trivial, or negative) (19). The magnitude of the change was 
determined with the following descriptors (1): <1%, almost certainly not; 1–5%, very unlikely; 
5–25%, unlikely or probably not; 25–75%, possibly or may be; 75–95%, likely or probably; 
95–99%, very likely; >99%, almost certainly. The magnitude of change was termed “unclear” 
if the CL overlapped the positive and negative SWC thresholds. To detect significant individual 
effects, the 95% CL for percent changes of Hbmass were derived from the present TE of the 
Hbmass measurement (95% CL = ± 1.96 TE √2 1/√2) (17). 
 
 
Results 
Hemoglobin Mass 
After the same hypoxic dose, the absolute Hbmass of the HH (d = 0.5, P < 0.001, +4.4%) and 
NH (d = 0.5, P < 0.001, +4.1%) groups increased to the same extent (Table 1). Similar increases 
were also observed for the relative Hbmass values in the HH (d = 0.6, P < 0.001, +4.3%) and NH 
(d = 0.4, P < 0.001, +3.8%) groups. After 18 days, Hbmass was not further increased in the HH 
group either for absolute (d = 0.5, P < 0.001, +4.5%) or relative (d = 0.6, P < 0.001, +4.5%) 
values. No significant change in the CON group was observed either for absolute (d = 0.1, P = 
0.08, +1.9%) or relative (d = 0.2, P = 0.46, +1.0%) values. Absolute and relative Hbmass changes 
did not differ between the groups with the same hypoxic dose (P > 0.75), as well as after 18 
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days (P > 0.12). The likelihood of %Hbmass changes in the altitude groups was likely beneficial 
compared to CON (>79% positive), with an unclear effect (>50% trivial) between the HH and 
NH groups after the same hypoxic dose and after 18 days (Table 2). Individual absolute Hbmass 
responses ranged from –0.1 to +10.6% in the HH group, from –1.4 to +7.7% in the NH group 
and from -3.3 to + 6.0% in the CON group. The 95% CL for %Hbmass changes were ± 3.7% and 
the upper CL was exceeded by most of the subjects in the altitude groups (Figure 2). 
 
Figure 2. Percent changes in hemoglobin mass of each athlete (open circle) and mean changes of each group 
(filled circle) after 18-day LHTL and after the same hypoxic exposure (230 h). The 95% confidence limits (95% 
CLs) are indicated by dotted lines. 
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Table 1 Hemoglobin mass (Hbmass) and hematological parameters before (Pre) and after (Post) the 18-d LHTL training camp for hypobaric 
hypoxia (HH), normobaric hypoxia (NH) and control (CON). As well for the similar hypoxic dose (230 h and 238 h) in HH and NH. 
Group Time Hypoxia  Hbmass  Hbmass  RBC  Hb  Hct  Ret  Ftn  EPO  
  (h) (g) (g/kg) (uµL-1) (gdL-1) (%) (%) (µgL-1) (mUmL-1) 
           
        
HH Pre 0 886 ± 80 12.9 ± 0.9 5.2 ± 0.6 15.2 ± 1.3 45.4 ± 3.6 1.1 ± 0.3 119.3 ± 128.1 5.0 ± 1.3 
 Day 13 230 927 ± 105* 13.5 ± 1.0* 5.0 ± 0.6 14.8 ± 1.6 44.4 ± 4.2 1.0 ± 0.4 75.8 ± 48.3 5.9 ± 1.7 
 Post 316 927 ± 95* 13.5 ± 1.0* 5.2 ± 0.5 15.3 ± 1.1 45.8 ± 3.1 1.0 ± 0.4 77.5 ± 68.4* 3.0 ± 0.7* 
                 
NH Pre 0 955 ± 83 13.6 ± 1.4 5.1 ± 0.5 15.1 ± 1.3 45.2 ± 3.7 1.3 ± 0.5 91.3 ± 49.9 6.3 ± 2.4 
 Post 238 994 ± 81* 14.1 ± 1.1* 5.3 ± 0.4* 15.7 ± 0.9* 47.1 ± 2.5* 1.2 ± 0.2 87.2 ± 44.7 3.1 ± 1.4* 
           
CON Pre 0 945 ± 128 13.1 ± 0.7 5.2 ± 0.5 15.1 ± 1.0 44.6 ± 3.4 1.3 ± 0.6 141.1 ± 91.9 4.8 ± 1.4 
 Post 0 963 ± 137 13.2 ± 0.7 5.2 ± 0.3 15.2 ± 0.7 45.1 ± 2.4 1.1 ± 0.4 147.1 ± 98.2 4.4 ± 1.6 
           
          
ANOVA 
(interaction group x time) 
P < 0.05 0.18 0.15 0.25 0.18 0.24 0.93 0.15 0.003 
          
RBC = red blood cells, Hb = hemoglobin concentration, Hct = hematocrit, Ret = reticulocytes, Ftn = serum ferritin concentration. Data are mean ± SD, *significant difference 
between different levels of time (P < 0.05). 
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Performance 
In the post-test compared to pre-test, the 3-km running time decreased with a moderate effect 
in the HH (from 643 ± 57 s to 618 ± 51 s, d = 0.5, P < 0.001, –3.9%) and NH (from 623 ± 47 s 
to 602 ± 36 s, d = 0.5, P < 0.001, –3.3%) groups and had a small effect in the CON group (from 
632 ± 59 s to 619 ± 56 s, d = 0.2, P = 0.031, –2.1%). Cycling maximal aerobic power did not 
change significantly in the HH (405 ± 51 W vs. 414 ± 45 W, d = 0.2, P = 0.08, +2.4%), NH 
(393 ± 36 W vs. 402 ± 35 W, d = 0.3, P = 0.08, +2.4%), or CON (423 ± 57 W vs. 424 ± 58 W, 
d = 0.0, P = 0.89, +0.2%) group. Running (P = 0.27) and cycling (P = 0.5) performance changes 
did not differ between the groups. The performance gains in the altitude groups were likely 
higher compared to the CON group (>64% positive), with an unclear effect (>39% trivial) 
between the HH and NH groups (Table 2). There was a large correlation between the relative 
Hbmass and 3-km running time percent changes from the pre-test to the post-test in the altitude 
groups (r = -0.64, P < 0.001) (Figure 3). 
 
Figure 3. Linear regression (and 95% CL) for percent changes from pre- to post-intervention in hypobaric hypoxia 
(HH) and normobaric hypoxia (NH) between relative Hbmass and 3-km running time. Regression slope (solid line) 
and 95% CL (dashed lines) are shown. 
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Table 2 Differences in hemoglobin mass (Hbmass) and performance improvements after 18-d 
LHTL camp between hypobaric hypoxia (HH), normobaric hypoxia (NH) and control (CON). 
Parameter Compared Groups 
Mean 
(%) 90% CL 
Qualitative 
outcome1 positive
 trivial negative
       
        
Hbmass HH vs. CON 2.6 ± 2.4 Likely beneficial  88%  11% 1% 
        
 NH vs. CON 2.2 ± 2.6 Likely beneficial  79% 19%  2% 
        
 HH vs. NH 0.4 ± 2.0 Unclear  30% 57% 13% 
        
 HH vs. NH (same dose) 0.3 ± 2.5 Unclear  30% 50%  20% 
        
3-km run HH vs. CON 1.9 ± 1.9 Likely beneficial  80%  19%  1% 
        
 NH vs. CON 1.3 ± 1.5 Possibly beneficial 64% 36% 1% 
        
 HH vs. NH 0.6 ± 2.0 Unclear  37% 55%  8% 
        
Pmax HH vs. CON 2.1 ± 3.0 Likely beneficial  74%  22%  4% 
        
 NH vs. CON 2.1 ± 2.5 Likely beneficial  78% 20% 2% 
        
 HH vs. NH 0.0 ± 3.3 Unclear  31%  39%  30% 
        
Pmax = maximal power output, Mean = differences in mean, CL = confidence limits. 1 With references to a 
smallest worthwhile change of 1% for performance and Hbmass. Group comparison was calculated first group 
minus second group. 
Blood Parameters 
Table 1 lists all hematological parameters. After the training camp, there was a moderate 
increase in Hct (d = 0.6, P = 0.04, +4.6%), Hb (d = 0.6, P = 0.02, +4.8%), and RBC (d = 0.4, P 
= 0.03, +4.2%) for NH with no such changes in the HH and CON groups (d < 0.2, P > 0.58). 
Ftn decreased to a small extent in the HH group (d = 0.4, P = 0.02), but not in the NH (d = 0.1, 
P = 0.92) or CON (d = 0.1, P = 0.79) group. A decrease in EPO in the HH (d = 1.9, P < 0.001, 
–39.4%) and NH (d = 1.6, P < 0.001, –51.3%) group compared to the CON (d = 0.3, P = 0.48, 
–8.4%) group was observed. A group x time interaction was detected only for EPO (P < 0.001), 
whereas other hematological parameters did not differ between the groups. 
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Training Load and Body Weight 
No differences were found in daily training loads between the groups (213.6 ± 29 vs. 205.2 ± 
16 vs. 155.4 ± 71 ECOs for the NH, HH, and CON groups, respectively) during the training 
camp (P = 0.21). Body weight did not differ (P = 0.76) between the groups. Pre-body weight 
was 68.6 ± 6.5, 70.4 ± 4.8, and 72.1 ± 8.2 kg, and post-body weight was 68.6 ± 5.6, 70.6 ± 4.9, 
and 72.7 ± 8.5 kg for the HH, NH, and CON groups, respectively. 
 
 
Discussion 
To our knowledge, the present study is the first to compare Hbmass response after the same 
hypoxic dose (approximately 230 h) in normobaric and hypobaric LHTL training camps. The 
main findings indicate that HH and NH yield a similar group mean increase in Hbmass after the 
same hypoxic dose and that the difference between HH and NH was unclear with a tendency to 
be trivial. After the 18 days of LHTL, NH and HH likely had beneficial effects on Hbmass and 
on performance indicators compared to the CON group, and despite a larger hypoxic dose in 
the HH group (316 h), the differences between HH and NH remained unclear. There was a wide 
variability in individual Hbmass response to NH and HH after the same hypoxic dose and after 
18 days. 
Mean Hbmass Responses 
The altitude groups demonstrated a similar group mean increase in Hbmass after the same 
hypoxic dose (+4.4% vs. +4.1%) to LHTL at 2250 m. The Hbmass increase was of similar 
magnitude to that observed by other LHTL studies (12, 15). It is well accepted that an adequate 
hypoxic dose of >12 h/day at sufficient altitude for >21 days (25, 27), i.e., approximately 300 
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h (7) is recommended to substantially increase Hbmass. However, in the current study, both 
altitude groups enhanced their Hbmass by approximately 4% after approximately 230 h of 
hypoxic exposure at 2250 m, which is in accordance with other studies (12, 26). These studies 
also showed a measurable increase in Hbmass (3.0 - 3.5%) after 210 h of normobaric hypoxic 
exposure at 3000 m (26) and after 236 h of hypobaric hypoxia at 2760 m (12). Furthermore, 
due to the nature of natural altitude, the HH group accumulated hypoxic hours much faster than 
the NH group (17 h·day–1 vs. 13 h·day–1) and achieved a similar hypoxic dose (approximately 
230 h) after 13 days of altitude training compared to the NH group (18 days), with no additional 
group mean Hbmass increase in HH (+4.4% vs. +4.5%) by day 18 (316 h). This suggests that 
approximately 230 h of hypoxic exposure at 2250 m in either HH or NH is sufficient to increase 
Hbmass in endurance athletes and that these erythropoietic adaptations were feasible within a 
shorter duration of hypoxic exposure than commonly recommended (26). Otherwise, altitude 
studies have shown that Hbmass increases at a mean rate of 1.1%/ 100 h of exposure (14), 
expecting a further Hbmass increase of ~1% from day 13 to day 18 in the HH group. However, 
there is a wide individual variability in the time course of Hbmass response to altitude training 
(7, 12), which was also present in the HH group from day 13 to day 18 (Figure 2). Some of the 
athletes could further increase their Hbmass from day 13 to day 18 (+0.9 to +5.4%), whereas in 
others Hbmass decreased from day 13 to day 18 (-1.8 to -6.0%). Furthermore, even using 
duplicate Hbmass measurements it is still difficult to certainly detect Hbmass changes smaller than 
the TE (1.3%). Therefore, it might be possible that the lack of increase in Hbmass from day 13 
to day 18 in HH is due to individual variation in the time course of Hbmass responses and due to 
measurement error. Last, the %Hbmass changes in both altitude groups were likely beneficial 
(>79% positive) in comparison to the CON group, indicating that LHTL either in HH or NH is 
advantageous for Hbmass increase compared to sea-level training. However, the difference 
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between Hbmass response in the NH and HH groups was unclear with a tendency to be trivial 
after the same hypoxic dose (50%) and after 18 days of LHTL (57%) (Table 2). 
Individual Hbmass Responses 
There was large variability in the individual responsiveness in Hbmass for HH (ranging from –
0.1 to +10.6%) and NH (from –1.4 to +7.7%) after the same hypoxic dose and 18 days of LHTL. 
The 95% CL for %Hbmass changes were ± 3.7% and the upper CL was exceeded mainly by the 
athletes in the altitude groups (HH: 7 out of 11 and NH: 6 out of 10), whereas only one athlete 
in the CON group exceeded the 95% CL (Figure 2). Since in all athletes no depleted ferritin 
stores (Ftn >30 µg·L–1) (16), doping abuse (doping control scores within normal ranges (31)), 
or different daily training loads during the altitude stay were detected and all measures were 
performed in duplicate with no measurement outliers, it can be expected that the athletes who 
exceeded the 95% CL were “true” Hbmass responders to altitude training at 2250 m in either NH 
or HH. Individual variability in Hbmass response to LHTL training camps (2700–3000 m) in 
either HH or NH has been shown and discussed before (7, 15, 29). However, studies (7, 15, 23, 
26, 29, 40) that focused on individual Hbmass response were mainly based on single measures 
of Hbmass with the optimized CO rebreathing method, which makes the differentiation between 
physiological and technical variation more difficult. The optimized CO rebreathing method is 
a very precise tool for determining Hbmass in athletes with a TE of approximately 2% (14). 
However, a greater certainty about individual Hbmass measures can be attained with duplicate 
Hbmass measurements, which improve the measure precision, as they reduce the TE by a factor 
of √2 (30%) (12) and help detect heavy measurement outliers (14). The more precise the Hbmass 
measurements, the greater the certainty about the individual responsiveness to an altitude 
training. Thus, it seems to be certain that within a mean Hbmass response of +4.1% to +4.5% 
after the LHTL camp, individual responsiveness in Hbmass from –1.4 to +10.6% exists.  
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The cause of such individual variability is still uncertain and may be related to several factors, 
such as a greater acute and sustained increase in erythropoietic and training-velocity response 
to altitude exposure (6). It has been suggested that the individual variability in Hbmass response 
may be explained by the initial Hbmass level, assuming that athletes with an already high initial 
Hbmass level have a limited ability to further increase their Hbmass after altitude training (28). 
However, in the current study, even athletes with an initial high Hbmass level could increase 
their Hbmass above the 95% CL (e.g., 1024 g to 1075 g, +5%). Overall, there was a trivial 
relationship between the baseline Hbmass (g) and the relative increase in absolute Hbmass (%) (r 
= 0.02, P = 0.92), indicating that even endurance athletes with already high Hbmass can benefit 
from LHTL training for further Hbmass improvement. To ensure the wide individual variability 
in Hbmass response to HH and NH, a cross-over study with the same athletes and a similar 
hypoxic dose of NH and HH would be needed. 
Performance 
Changes in running and cycling performance were likely beneficial (64–80% positive) in the 
HH and NH groups compared to the CON group (Table 2). The greater performance 
improvement in the altitude groups (+1.2% to +2.2%) compared to the CON group is of similar 
magnitude as reported in other LHTL training interventions under normobaric conditions (13, 
29) and under hypobaric conditions (39, 41). Whereas the differences between HH and NH in 
the magnitude of performance changes were unclear. Bonetti and Hopkins (3) reported in a 
recent meta-analysis on altitude training that natural LHTL might be more beneficial for elite 
(4.0%; 90% CL ± 3.7% vs. 0.6%; ± 2.0%) and sub-elite (4.2%; 90% CL ± 2.9% vs. 1.4%; ± 
2.0%) athletes than artificial protocols. However, due to the unequal hypoxic doses in the 
present study and the conflicting results reported in the literature (i.e., uncontrolled studies, 
poor study design, differences in duration and intensity of hypoxic exposure and subject 
training status (22)), the present results and literature cannot reflect a direct comparison of 
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LHTL in HH versus NH in performance responses. Therefore, a cross-over study with the same 
athletes exposed to HH and NH is needed to confirm the present results. 
Currently, one of the most recognized physiological mechanisms leading to enhanced sea-level 
performance after LHTL is an hypoxia-induced increase in Hbmass (14, 39). Changes in Hbmass 
directly affect V̇O2max, a key parameter in endurance performance (22, 36); accordingly, cross-
sectional studies showed that an increase of 1 g in Hbmass results in an approximate 4 mL·min 1 
rise in V̇O2max at sea level (32, 36). There is also evidence that the gain in V̇O2max following 
altitude training is related to the increase in Hbmass (22, 29, 32), whereas an increase in Hbmass 
was reported with different performance outcomes (13, 15, 29). The present study demonstrated 
a large correlation between the percent changes in relative Hbmass (g·kg–1) and 3-km running 
time for both altitude groups (r = -0.64, P = 0.002) (Figure 3). Since 3-km running time is close 
to velocity at V̇O2max (2), it can be suggested that in the present study the improvement in 
running performance may be directly linked to the changes in Hbmass after 18-day LHTL in 
either HH or NH. 
Blood Parameters 
The majority of the hematological parameters were similar between the HH and NH groups 
before and after the 18-day LHTL training camp. EPO was lower in both groups after the LHTL 
training camp compared to the CON group, which is in line with previous findings (5, 7, 40), 
showing that EPO increases at the beginning of altitude exposure and peaks within 2–3 days 
before beginning to decrease toward sea-level values. It has been suggested that low iron stores 
(Ftn <30 µg·L–1) interfere with Hbmass responses to hypoxic exposure and may reduce the 
effectiveness of altitude training (38). In the present study, the ferritin levels were above >30 
µg·L–1 in all athletes and only a small correlation between the initial ferritin level and the 
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Hbmass responses (r = 0.3, P = 0.095) was detected. However, one cannot rule out that low 
ferritin levels may limit Hbmass responses to altitude training. 
Study Limitations 
This study primarily aimed to compare Hbmass changes after the same hypoxic dose and after 
18-day LHTL training camps in either NH or HH. Important notes for consideration in 
evaluating the findings are that the study settings replicated common real altitude training 
practices of endurance athletes (e.g., daily exposure, total hypoxic doses under NH and HH 
conditions, respectively). Thus, the reported total (238 h vs. 316 h) and daily (13 h vs. 17 h) 
hypoxic exposure in the present study was lower in the NH group than in the HH group. To 
directly compare the same hypoxic dose between the two conditions, we performed an 
additional Hbmass measurement in the HH group at day 13 of the training camp (230 h vs. 238 
h for HH and NH, respectively). However, one cannot rule out that the unequal nature of the 
daily hypoxic dose in HH and NH could have influenced the results. Since the primary aim of 
the study was to compare Hbmass changes between normobaric and hypobaric LHTL after the 
same hypoxic dose and the secondary aim was to compare differences in Hbmass and 
performance changes after 18-day LHTL in either HH or NH, it was planned not to measure 
performance parameters on day 13 because it would have influenced the training load 
quantification. Therefore, we cannot exclude putative differences in running or cycling 
performance with the same hypoxic dose between HH and NH. Another key consideration is 
the small sample size in the three training groups, which could explain the missing statistical 
significance between the altitude groups and the control group, but the magnitude of changes 
in Hbmass and performance was still likely positive for the NH and HH groups compared to the 
CON group. Furthermore, we cannot exclude that the hematological concentration values were 
slightly affected by the suboptimal standardization of the venous blood sampling (travel, fluid 
intake, etc.). Lastly, to control our findings regarding individual variability in Hbmass response 
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to HH and NH, a cross-over design with a similar hypoxic dose of NH and HH would be needed. 
However, due to different periods of the athlete’s training (e.g., competition period, off-season, 
tapering or peaking), a cross-over design with athletes is only feasible if the interventions take 
place at the same time point of the season. 
 
 
Conclusion 
Hypobaric and normobaric LHTL evoked a similar group mean increase in Hbmass (4.4% vs. 
4.1%) after same hypoxic dose (230 vs. 238 h): The difference between HH and NH was unclear 
with a tendency to be trivial. After the 18-day LHTL training camp, both NH and HH likely 
have beneficial effects on Hbmass and on performance indicators compared to the CON group, 
whereas the differences between HH and NH were also unclear, despite a larger hypoxic dose 
in the HH group (316 h). Individual Hbmass responses demonstrated a large variability in the 
altitude groups, underlining the importance of individual evaluation of Hbmass responses to 
altitude training. 
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Dear Editor-in-Chief, 
We thank Dr. Siebenmann for the interest in our study. He wrote, that one should be careful to 
interpret the increase in hemoglobin mass (Hbmass) unambiguously as a response to altitude. We 
agree with this point, as several studies have shown that Hbmass can be slightly increased after 
a training camp, especially when subjects are not at top-elite level (7). Our current results 
support this, as there was a tendency (P = 0.08) but not a significant effect of Hbmass to be 1.9% 
“elevated” after 18 d endurance training in our control group (4). However, our main goal was 
not to distinguish between the altitude and training effect, but between the effect of normobaric 
and hypobaric “live hightrain low” (LHTL). Further, Dr. Siebenmann expressed the opinion 
that three aspects of the hematological results differ from those typically observed at altitude. 
First, he noted a “relatively high” increase in Hbmass (4.4%) already at day 13 (230 h) in the HH 
group (2250 m). In our opinion, these results do not differ from typical LHTL altitude training 
studies that have indicated similar increases in Hbmass after 14 d. For example, Garvican-Lewis 
et al. (2) reported Hbmass increases between 3.7% and 4.5% after LHTL blocks lasting as short 
as 9 to 11 d. Gore et al. (3) suggest in their comprehensive meta-analysis that an increase of 
1.1%/100 h of adequate altitude exposure can be expected. This would result in a 2.5% increase 
after 230 h; however, the “upper 95% response limit” for 230 h in this study was around 5%. 
Interestingly, Dr. Siebenmann himself reported increased Hbmass (+3.5%) already at day 12 at 
altitude (8). Our individual Hbmass increase after 13 d varied between 0% and +10%. It can 
therefore be reasoned, that group composition (i.e. Hbmass-responder vs Hbmass-nonresponder) 
can noticeably influence the mean Hbmass response. 
Second, Dr. Siebenmann pointed out that erythropoietin was not elevated at day 13. In our 
opinion, our results also align well with other studies, where erythropoietin values increase 
during the first days at altitude and then return to pre values after around 10–14 d. For example, 
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Chapman et al. (1) demonstrated in four different LHTL altitude training groups (living 
altitudes 1780, 2085, 2454, and 2800 m) that erythropoietin returned to pre altitude levels at 7, 
14 and 21 d in all the four LHTL groups. 
Third, Dr. Siebenmann noted the slightly reduced hematocrit values compared with baseline. It 
is well known that plasma volume is easily changed by a variety of short-term factors (6). As 
already indicated (4), we think that these data should not be overinterpreted, since hematocrit 
values at pretests were potentially elevated due to the long travel and suboptimal fluid intake. 
In summary, we emphasize, that all Hbmass measurements were made in duplicate (5) and with 
a high level of documented reproducibility (4). Furthermore, we wish to reinforce, that our 
hematological values compare favorably with those typically observed within LHTL studies. 
Finally, an interesting aspect for future research is the varied individual Hbmass responses 
detected in triathletes. 
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Abstract 
Purpose: To compare individual hemoglobin mass (Hbmass) changes following a live high–train 
low (LHTL) altitude training camp under either normobaric hypoxia (NH) or hypobaric 
hypoxia (HH) conditions in endurance athletes. Methods: In a crossover design with a one-
year washout, 15 male triathletes randomly performed two 18-d LHTL training camps in either 
HH or NH. All athletes slept at 2250 m and trained at altitudes < 1200 m. Hbmass was measured 
in duplicate with the optimized carbon monoxide rebreathing method before (pre-) and 
immediately after (post-) each 18 d training camp. Results: Hbmass increased similarly in HH 
(916 to 957 g, 4.5 ± 2.2%, P < 0.001) and in NH (918 to 953 g, 3.8 ± 2.6%, P < 0.001). Hbmass 
changes did not differ between HH and NH (P = 0.42). There was substantial inter-individual 
variability among subjects to both interventions (i.e., individual responsiveness, or the 
individual variation in the response to an intervention free of technical noise): 0.9% in HH and 
1.7% in NH. However, a correlation between intra-individual delta Hbmass changes (%) in HH 
and in NH (r = 0.52, P = 0.048) was observed. Conclusion: HH and NH evoked similar mean 
Hbmass increases following LHTL. Among the mean Hbmass changes, there was a notable 
variation in individual Hbmass response, which tended to be reproducible. 
 
New & Noteworthy 
This is the first study to compare individual Hbmass response to normobaric and hypobaric 
LHTL using a same-subject crossover design. The main findings indicate that hypobaric and 
normobaric hypoxia evoked a similar mean increase in Hbmass following 18-d LHTL. Notable 
variability and reproducibility in individual Hbmass responses between athletes was observed, 
indicating the importance of evaluating individual Hbmass response to altitude training.  
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Introduction 
Simulated and natural altitude training methods are commonly used by elite endurance athletes 
to enhance sea-level performance (25, 45). The question as to, whether simulated (normobaric 
hypoxia) altitude and natural (hypobaric hypoxia) altitude differ considerably regarding 
physiological and performance responses is still debated (5, 26, 32). A frequently used altitude 
training method, which can be performed under either hypobaric or normobaric conditions, is 
the “live high–train low” (LHTL) model (22, 41), where athletes live and sleep at a certain 
altitude but train at a lower altitude or near sea-level (1, 45). However, researchers have rarely 
directly compared the possible differences between the effects of hypobaric and normobaric 
LHTL on relevant physiological responses, such as hemoglobin mass (Hbmass) (16) and 
performance responses (32). Thus far, only one study (16) has compared individual Hbmass 
responses between normobaric and hypobaric LHTL training camps after the same duration (18 
d) and the same hypoxic hours (approximately 230 h) in endurance athletes. Interestingly, these 
results showed that hypobaric and normobaric LHTL evoked similar group mean increases in 
Hbmass (4.1% vs. 4.5%) and that there was no difference between the two hypoxic conditions. 
In line with previous studies (6, 8, 24, 30, 38, 43), individual Hbmass responses demonstrated a 
wide variability (–1.4% to 10.6%) in hypobaric and normobaric LHTL. As the number of 
athletes was small within the hypobaric hypoxia (HH) and normobaric hypoxia (NH) groups (n 
= 10, 11), an uneven distribution of athletes who responded positively or less positive to altitude 
in Hbmass may have affected the outcome. Thus, the question whether normobaric and hypobaric 
LHTL results in similar Hbmass responses has not been conclusively answered. The 
straightforward option to diminish the observed effect is to conduct a same-subject crossover 
design. 
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The primary aim of the present study was to investigate whether Hbmass responses differ 
between 18-d hypobaric and normobaric LHTL with a same-subject crossover design. The 
secondary aim was to quantify individual Hbmass responsiveness in HH and NH. 
 
 
Methods 
Subjects 
Fifteen well-trained male triathletes, living at or near sea level (age: 23.9 ± 4.0 yr, height: 178.5 
± 4.9 cm and weight: 64.9 ± 7.6 kg) completed both altitude training camps and fulfilled the 
following inclusion criteria for participation and data analysis: 1) a minimum of 5 yr of 
endurance training and frequent participation in endurance competitions, 2) initial ferritin levels 
> 30 µg·L–1, and 3) no doping abuse (OFF score within reference range (11)). All athletes 
provided written informed consent to participate in the study. The study was approved by the 
local ethical committees (Commission Cantonale Valaisanne d’Ethique Médicale, CCVEM; 
Agreement 051/09 and French National Conference of Research Ethics Committees; N°CPP 
EST I: 2014/33; Dijon, France), corresponding to the two training locations. All procedures 
were conducted in accordance with the Declaration of Helsinki. 
Study design 
Originally, it was planned to perform a single parallel group study design (camp 1). To get a 
crossover study design, we decided after the first training camp to extend the study with another 
training camp (camp 2), but however only with those athletes, but not all athletes from the first 
training camp were able to participate a second time. Thus, the present study was based on two 
training camp phases performed over one year. In the first year (camp 1), a total of 24 athletes 
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were randomly assigned to either a hypobaric or a normobaric hypoxic 18-d LHTL training 
camp. In the second year (camp 2), at the same time point during the year and during the 
competitive season, 15 of the 24 athletes performed a second 18-d LHTL training camp with 
the opposite hypoxic condition (HH or NH). Individual Hbmass responses of one single training 
camp have been published; for details see Hauser et al. (16). To have a same-subject crossover 
design (Fig. 1), only the results of these 15 athletes were used in this study. The athletes’ data 
were pooled for each hypoxic condition from both camps of the study as follows: HH condition 
included the pooled values from the HH athletes in camp 1 (n = 5) and the HH athletes in camp 
2 (n = 10); the same athletes were considered for the NH condition but reversed (n = 10 in camp 
1 and n = 5 in camp 2). During the one-year washout period, the athletes did not perform any 
additional altitude training. Under both hypoxic conditions (NH and HH), athletes slept at an 
altitude of 2250 m and trained at altitudes < 1200 m. Immediately before (pre-) and after (post-
) each training camp, Hbmass was measured in duplicate, and venous blood samples were 
collected. At day 13 of the second training camp in HH (camp 2), in 10 of 15 subjects, an 
additional duplicate Hbmass measurement was performed, as it corresponded to the expected 
hypoxic hours in NH after 18 d (matched hypoxic hours in HH and NH). All measurements 
were performed at 1150 m. During the training camp, training load and hypoxic hours were 
continuously recorded. 
Hypoxic exposure 
For the LHTL training camps under HH, the athletes lived in Fiescheralp, Switzerland (2250 
m, inspired oxygen pressure (PiO2) 111.6 ± 0.6 mm Hg, inspired oxygen fraction (FiO2) 20.9 ± 
0.0%, barometric pressure (PB) 580.2 ± 2.9 mm Hg) and traveled by cable car twice daily to the 
valley (altitude < 1200 m) for training. Daily hypoxic exposures in HH totaled 17.3 ± 2.3 h. 
The total hypoxic hours after 18 d were 311.6 ± 7.8 h and after 13 d (only measured in the 
second camp, n = 10) 229.5 ± 1.2 h, respectively. For the LHTL training camps under NH, the 
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athletes lived in Prémanon, France (1150 m) and were exposed to normobaric hypoxia 
equivalent to 2250 m in hypoxic rooms (medium size: 15 m2). Normobaric hypoxia was 
obtained by extracting oxygen from ambient air in hypoxic rooms (PiO2 111.9 ± 0.6 mm Hg, 
FiO2 18.05 ± 0.1%, PB 666.6 ± 3.6 mm Hg). In each hypoxic room, the gas composition was 
continuously monitored with oxygen and carbon dioxide analyzers (FIELDBROOK Ltd, 
London, UK), which were connected to a central monitoring station under the control of an 
experienced physiologist. In Prémanon, the athletes left the hypoxic rooms on average 5–6 
times per day to eat and train. Daily hypoxic exposures in NH totaled 12.5 ± 0.4 h, and the total 
hypoxic hours after 18 d were 225.3 ± 9.0 h. During all training camps, the time spent in hypoxia 
was monitored daily and recorded manually. 
 
 
Figure 1. Illustration of the study design (n =15). 
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Training load 
All training sessions during the training camps were advised and supervised by two experienced 
certified coaches. The intervention groups trained separately (located at two different places: 
Fiesch, Switzerland and Prémanon, France) under the supervision of one coach. The training 
consisted of cycling, running, and swimming. Training load quantification was performed using 
the Objective Load Scale (ECOs; (2)), which was specially developed for training load 
quantification in triathlons. Briefly, the ECOs were calculated by multiplying the total duration 
of a training session (time in minutes) with a scoring value between 1 and 50, depending on the 
heart rate based training zone (1 to 8) and by a factor of 1.0, 0.75, or 0.5 for running, swimming, 
or biking, respectively. The daily training loads (ECOs) of each subject were measured based 
on each subject’s physical characteristics and training program intensity. 
Hemoglobin mass 
Hbmass was measured in duplicate using a slightly modified version of the optimized carbon 
monoxide (CO)-rebreathing method described by Schmidt and Prommer (36). Briefly, a CO 
dose of 100 mL (Multigas SA, Domdidier, Switzerland) was administered and rebreathed with 
3.5 L oxygen for 2 min in a closed circuit system (glass spirometer, Blood Tec GbR, Bayreuth, 
Germany). Capillary earlobe blood samples (35 µl) were collected three times before the CO-
rebreathing procedure and once at minute 6 and 8 after CO rebreathing was started. Blood 
samples were analyzed for carboxyhemoglobin (%HbCO) using a CO-oximeter (ABL 800flex, 
Radiometer A/S, Copenhagen, Denmark). Hbmass was calculated from the mean change in 
%HbCO before and after CO rebreathing, as described previously by Steiner and Wehrlin (39). 
Both measurements were performed on two consecutive days (12–24 h time lag between the 
measures), and the results were averaged. The typical error (TE) of Hbmass measurement was 
calculated from duplicate measurements as the standard deviation (SD) of the difference score 
divided by √2 (17). To provide a dimensionless measure of reliability, which is comparable 
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between subjects and studies (17), the TE was translated into a coefficient of variation (CV). 
The CV is calculated by dividing the TE by the mean value of Hbmass and is expressed in 
percent. Averaged multiple measurements reduce the TE by a factor of 1/ √n, where n is the 
number of measurements (17). In this study, the TEs for duplicate measurements of Hbmass at 
the different time points were as follows: pre-camp 1: 1.8% (90% confidence limits (CLs): 1.3–
2.5%); post-camp 1: 1.0% (0.7.1–1.3%); pre-camp 2: 0.9% (0.7.1–1.3%); day 13: 1.9% (1.3–
2.6%); post-camp 2: 1.1% (0.8–1.6%). In our mobile laboratory, the overall TE of the CO-
rebreathing method was 2.0% (1.5–2.6%), and the TE for the average duplicate measurements 
was 1.4% (1.1–1.8%). 
Ferritin and OFF score 
On the first morning in the pre- and post-testing of both training camps, venous blood samples 
were drawn from an antecubital vein (4.9 ML EDTA tube, Sarstedt, Nümbrecht, Germany) 
immediately after the athletes woke up (7 am). To identify iron-deficient athletes (initial ferritin 
levels > 30 µg·L–1), serum ferritin concentration analysis was determined with a biochemistry 
analyzer (Dimension EXL, Siemens Healthcare Diagnostics SA, Zürich, Switzerland). The CV, 
which was determined using internal quality controls, was 4.5%. To exclude the potential risk 
of illegal blood manipulation, athletes were tested for doping by an accredited laboratory (Swiss 
Laboratory for Doping Analyses, Lausanne, Switzerland). Therefore, the OFF score (OFF score 
= Hb (g·L-1) - 60√(reticulocytes in %)) according to Gore et al. (11) was calculated and 
compared to cut-off limits for athletes tested at altitude > 610 m with a false positive rate of 
1:100. 
Statistical analyses 
Values are presented as means ± SD. All data were checked for normality (Shapiro-Wilk test) 
and equality of variance. A two-way repeated measure analysis of variance was applied to 
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evaluate the differences between the conditions (HH and NH) over time. When a significant 
global effect was indicated, Tukey’s post-hoc test was performed to identify significant 
differences between different levels of time and conditions. For a comparison of the training 
load between HH and NH, a paired t-test was performed. Linear regressions were used to 
determine the Pearson’s correlation coefficient (r) between individual delta Hbmass changes (%) 
in HH and in NH. The level of significance was set at P < 0.05. All analyses were processed 
using Sigmaplot 11.0 (Systat Software, San Jose, CA, USA). 
To assess the likelihood that the differences in percent change in Hbmass between HH and NH 
were relevant (i.e. more extreme than the smallest worthwhile change in Hbmass, set to ± 1%) a 
contemporary statistical approach according to Hopkins (18) was used. This approach 
calculates the chances (in %) that the true value of an effect is positive, trivial or negative. To 
classify the magnitude of the effects (positive, trivial, or negative), the change in mean and the 
90% CL of the individual change scores were used (19). The effect was termed “unclear” if its 
CL overlapped the positive and negative smallest worthwhile changes. Individual Hbmass 
responsiveness (i.e. the individual variation in the response to an intervention free of TE (17)) 
for NH and HH is expressed as the SD from the mean Hbmass change and was calculated as the 
square root of the difference between the variance of the Hbmass change scores in the 
intervention and the variance in change scores arising from TE only ((TE · √2)2). To detect 
significant individual effects, the 95% CL for percent changes of Hbmass was derived from the 
present overall TE of the Hbmass measurement (95% CL = ±1.96 · TE · √2 · 1/√2; (17)). 
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Results 
Mean Hbmass responses  
After 18 d (n = 15), Hbmass increased similarly in HH (916.0 ± 84.6 g to 957.1 ± 93.5 g, 4.5 ± 
2.2%, P < 0.001) and NH (918.0 ± 86.5 g to 952.6 ± 92.7 g, 3.8 ± 2.6%, P < 0.001; see Fig. 2). 
For matched hypoxic hours (n = 10), Hbmass increased by 4.9 ± 3.7% (891.7 ± 81.7 g to 936.2 
± 106.1 g, P < 0.001) in HH and by 3.4 ± 2.2% (883.4 ± 72.4 g to 914.0 ± 82.5 g, P = 0.005) in 
NH. Hbmass changes did not differ between the conditions after 18-d LHTL (P = 0.42) or for 
same hypoxic hours (P = 0.29). The chance in percent Hbmass changes being greater in HH 
compared to NH was 36% following 18-d LHTL and 61% for matched hypoxic hours (Table 1). 
 
 
 
Figure 2. Individual Hbmass (g) for before (Pre) and after (Post) 18 d of LHTL in either hypobaric or normobaric 
hypoxia, n = 15. 
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Table 1 Likelihoods of magnitudes of hemoglobin mass (Hbmass) changes between hypobaric 
hypoxia (HH) and normobaric hypoxia (NH) after 18-d LHTL camp and after matched hypoxic 
hours (230 h and 225 h). 
Compared       Groups Parameter Mean (%) 90% CL positive trivial negative 
        
        
HH vs. NH  18-d LHTL Hbmass (g) 0.7 ± 1.4 36%  61% 3% 
        
HH vs. NH  Same hypoxic hours Hbmass (g) 1.4 ± 2.3 61% 34% 5% 
        
Mean = differences in mean, CL = confidence limits. With references to a smallest worthwhile change of 1% 
for Hbmass. Comparison of groups always first group minus second group. 
 
Individual Hbmass responses  
Percent changes in individual Hbmass ranged from +0.4% to +8.7% in HH and from –1.4% to 
+7.7% in NH (Fig. 3) after 18-d LHTL. The 95% CL for individual percent Hbmass changes was 
± 3.9%, and the upper CL was exceeded by eight out of 15 athletes in HH and by seven out of 
15 athletes in NH. Individual responsiveness was ±0.9% in HH and ±1.7% in NH. For matched 
hypoxic hours, individual responsiveness was ±3.4% in HH and ±0.9% in NH. There was a 
significant correlation between individual delta Hbmass changes (%) in HH and in NH after 18-
d LHTL (r = 0.52, P = 0.048). 
Ferritin and OFF score 
Initial ferritin levels were > 30 µg·L–1 in all athletes. Pre-ferritin values were 108.1 ± 36.0 µg·L–
1 and 107.3 ± 36.3 µg·L–1 in HH and NH, respectively. All athletes were within the cut-off 
limits for the OFF scores (< 125.3) for pre- (91.7 ± 5.4 vs. 94.6 ± 14.1) and post- (97.2 ± 6.3 
vs. 97.9 ± 5.1) testing in HH and NH, respectively. 
 96 
 
Figure 3. Individual hemoglobin mass (Hbmass) changes (%) after 18 d of LHTL in hypobaric hypoxia (HH, 312 
h) or in normobaric hypoxia (NH, 225 h). The 95% limits (95% CLs) are indicated by dotted lines. 
 
Training load and body weight 
No differences were found in daily average training loads between the two groups, HH (217.6 
± 87.9 ECOs) and NH (229. ± 80.0 ECOs), during the 18-d LHTL training camps of the 
crossover study (P = 0.54). In camp 1, the daily training load was similar to that in camp 2 in 
HH (231.7 ± 42.1 vs. 210.6 ± 105.6 ECOs, P = 0.68) and NH (229.4 ± 25.2 vs. 228.6 ± 7.9 
ECOs, P = 0.98). Body weight did not differ over time between HH and NH after 18 d (P = 
0.72). The average pre-body weight was 70.3 ± 6.3 kg and 71.6 ± 7.6 kg, and the average post-
body weight was 69.8 ± 5.3 kg and 70.6 ± 6.4 kg — for HH and NH, respectively. 
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Discussion  
This is the first study to compare individual Hbmass responses to normobaric and hypobaric 
LHTL using a same-subject crossover design. The main findings indicate that HH and NH 
evoked a similar mean increase in Hbmass following 18-d LHTL. The mean changes in Hbmass 
did not differ between HH and NH. Notable variability in individual Hbmass responses following 
18-d LHTL in HH and NH was observed as well as a significant correlation between individual 
delta Hbmass changes (%) in HH and in NH. 
Mean Hbmass responses  
Both hypoxic conditions (HH vs. NH) demonstrated a similar mean Hbmass increase (+4.5% vs. 
+3.8%) following 18-d LHTL. Furthermore, the chance in percent Hbmass changes being greater 
in HH compared to NH was only 36%. Recently, the part study (16) of the crossover study also 
reported similar Hbmass responses after an 18-d LHTL training camp in either HH or NH, despite 
larger total hypoxic hours in HH compared to NH. A recent meta-analysis estimated that Hbmass 
increases at a mean rate of 1.1%/100 h of exposure at simulated or natural altitude (14), which 
would have expected lower mean Hbmass responses ( ̴1% to 2%) in the present study. However, 
in this meta-analysis, the “upper 95% individual response limits” for 225 h and 310 h were 
around 5% and 6%, respectively, indicating that group composition can noticeably influence 
the mean Hbmass response. The present mean Hbmass increases were of similar magnitude to 
previous LHTL studies with longer hypoxic exposures (> 300 h; (15, 44)) and were of greater 
magnitude than in LHTL studies with similar hypoxic hours (4, 20, 28). The current 
recommendation suggests an adequate hypoxic exposure of > 12 h·day-1 at natural or simulated 
altitude > 2000 m for > 21 d; that is, approximately 300 h is required to substantially increase 
Hbmass (4, 31). However, the data for the NH group after 18 d (225 h) and for the HH group 
after 13 d (230 h) suggest that a relevant Hbmass increase can be achieved with less hypoxic 
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hours (< 300 h) in some subjects. Recently, studies have examined earlier time courses (8, 43) 
and shorter hypoxic exposure (9, 27) on changes in Hbmass to moderate altitude (2500–3000 m). 
The data from these studies showed measurable Hbmass increases (2.1% to 3.7%) within a 
shorter time period (11–13 d) or lower hypoxic exposure (< 210 h) than recommended (14, 31). 
However, the present study and the reported studies (8, 9, 27, 43) used different athlete 
populations and applied different altitude protocols, which may limit generalization. Therefore, 
further research is needed to better understand the time course and dose–response relationship 
of Hbmass to different altitude protocols in different athlete populations.  
An hypoxia-induced increase in Hbmass seems to be one of the main physiological mechanisms 
leading to improved sea-level endurance performance after altitude training (14, 22, 23, 42). 
Hbmass is closely related to maximal oxygen uptake (V̇O2max) – that is, a gain of 1 g in Hbmass 
results in a 4 mLmin–1 increase in V̇O2max under normoxic conditions (37). Further, Hbmass 
correlates with time trial performance and maximal incremental power output in highly trained 
endurance athletes (21). In both 18-d LHTL camps, the athletes performed a 3-km running time 
trial near sea level before and after each camp. The mean performance data of both LHTL 
camps have been already published (34). If we correlate the percent changes in individual 
Hbmass data (in g·kg-1) of the present article with the individual performance data from the 
already published article (34), we obtain a correlation of r = -0.47 (P = 0.07) in HH and a 
correlation of r = -0.57 (P = 0.03) in NH. This is comparable to our previously published paper 
(16), where we reported also a correlation (r = -0.64, P = 0.002) between running performance 
improvements and increase in Hbmass (g·kg-1) after 18-d LHTL (n = 21), suggesting that the 
enhancement in endurance performance was directly linked to changes in Hbmass after LHTL. 
Whereas, there was no significant correlation between percent changes in individual 
performance and Hbmass (in g) in HH (r = -0.14, P = 0.61) and in NH (r = -0.35, P = 0.20). This 
in turn supports the literature showing an increase in Hbmass following altitude training with 
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different performance outcomes (7, 12, 30). Further, it seems that also nonhematological 
mechanisms such as improved mitochondrial efficiency and/or muscle pH regulation (13) can 
contribute to enhanced sea-level performance following altitude training. Thus, the impact of 
Hbmass increase on performance benefits following altitude training remains unclear. 
To date, whether the type of hypoxia (e.g., NH or HH) differs considerably regarding 
physiological and performance responses is still debated (5). Short-term exposure (< 26 h) to 
HH seems to evoke greater hypoxemia, lower oxygen arterial saturation (35), and more altered 
cycling time trial performance (33) compared to NH. Whereas long-term exposure of the same 
duration (e.g., following LHTL) to HH and NH induced similar Hbmass (16) and performance 
improvements (32, 34). The present crossover study confirmed that 18-d LHTL training at 2250 
m either in HH or in NH induced similar mean Hbmass responses, despite a larger number of 
hypoxic hours in HH compared to NH. Thus, from a practical point of view it seems that both 
hypoxic conditions (HH or NH) can be used equally for LHTL camps to enhance Hbmass. 
However, it must be considered that HH conditions can accumulate hypoxic hours much faster 
than NH, while NH conditions are logistically easier and more customizable than HH. 
Individual Hbmass responses and reproducibility 
Individual variability in Hbmass response to altitude training camps in either HH or NH has 
previously been shown and discussed (6, 8, 16, 38, 43); however, not many altitude training 
studies quantified individual responsiveness (24, 27, 29, 30). In the present study, individual 
Hbmass responsiveness (measure of individual responses that is free from the TE) was ±0.9% in 
HH and ±1.7% in NH , which was slightly lower compared to other studies demonstrating 
individual Hbmass responsiveness of ±1.3% to ±2.6% in HH (24, 29) and of ±1.4% to ±2.9% in 
NH (27, 30). Interestingly, after the same hypoxic hours in HH, the magnitude of individual 
Hbmass responsiveness was ±3.4%. This result was much greater than expected, suggesting that 
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it was due to measurement imprecision and that even with duplicate Hbmass measurements there 
is still a chance of random noise (14). The reason for individual variability in Hbmass response 
to altitude training remains to be clarified and can be attributed to many factors, such as 
individual variation in erythropoietic response to hypoxia (3, 6), genetic predisposition (46), 
occurrence of a mild neocytolysis after descending after return to sea level (6) or different 
baseline conditions such as low pre-altitude ferritin levels (40). Regarding the latter, in the 
present study, all individual ferritin levels were above > 30 µg·L–1 and an inverse correlation 
between the pre-altitude ferritin level and Hbmass (in g) changes (r = -0.30, P = 0.10) was shown 
suggesting that in the present study initial ferritin levels did not influence individual variability 
in Hbmass response. However, there is also evidence that low iron stores (< 30 µg·L–1) may 
impair Hbmass production and thus an individualized iron supplementation strategy during 
altitude training is recommended (10). 
To detect significant individual Hbmass responses, the 95% CLs for the percent changes of Hbmass 
were derived from the present overall TE, which was ±3.9%. The upper CL was exceeded by 
half the athletes in both hypoxic conditions (HH: eight of 15 and NH: seven of 15, Fig. 3). 
Because Hbmass was measured in duplicate, which reduces the TE by a factor of 1/ √2 (17) and 
thus enhances the measurement precision, the athletes who exceeded the 95% CL were likely 
responders in Hbmass to the altitude training in the current study. Further, most of the athletes 
who increased their Hbmass during the first LHTL altitude camp demonstrated a reproducible 
Hbmass response after the second LHTL altitude camp, suggesting that those athletes who 
responded once to altitude training will very likely respond another time regardless of the type 
of hypoxia. Previous studies focusing on reproducibility of Hbmass responses in athletes to 
altitude training camps (24, 43) have demonstrated reproducible mean percent Hbmass changes 
but only a small trend toward reproducible individual Hbmass changes, which is not in line with 
the present results. Thus, whether reproducibility in individual Hbmass responses to altitude 
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training camps and/or to different hypoxic conditions (HH vs. NH) exists remains unclear. 
Overall, the variability in individual Hbmass response to hypoxia detected in the present study 
emphasizes the importance of evaluating the individual Hbmass response of an athlete to altitude 
training camps. Therefore, we recommend measuring Hbmass in duplicate directly before and 
after an altitude training camp within a time lag of less than 24 h between the two 
measurements. 
 
 
Conclusion 
The findings of the present crossover study indicate that hypobaric and normobaric LHTL 
evoked a similar mean increase in Hbmass following 18-d LHTL. There was no difference in 
Hbmass changes between HH and NH. Notable variability in individual Hbmass responses 
between athletes was observed, indicating the importance of individual evaluation of Hbmass 
responses to altitude training.  
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Abstract 
Purpose: It has been proposed that athletes with high initial values of hemoglobin mass 
(Hbmass) will have a lower Hbmass increase in response to ‘live high-train low’ (LHTL) altitude 
training. To verify this assumption, the relationship between initial absolute and relative Hbmass 
values and their respective Hbmass increase following LHTL in male endurance and team-sport 
athletes was investigated. Methods: Overall, 58 male athletes (35 well-trained endurance 
athletes and 23 elite male field hockey players) undertook an LHTL training camp with similar 
hypoxic doses (200-230 h). Hbmass was measured in duplicate pre- and post-LHTL with the 
carbon monoxide rebreathing method. Results: While there was no relationship (r = 0.02, P = 
0.91) between absolute initial Hbmass (g) and percent absolute Hbmass increase, a moderate 
relationship (r = -0.31, P = 0.02) between initial relative Hbmass (g·kg-1) and percent relative 
Hbmass increase was detected. Mean absolute and relative Hbmass increased to a similar extent 
(P ≥ 0.81) in endurance (from 916 ± 88 to 951 ± 96 g, +3.8%, P < 0.001 and from 13.1 ± 1.2 to 
13.6 ± 1.1 g·kg-1, +4.1%, P < 0.001) and team-sport (from 920 ± 120 to 957± 127 g, +4.0%, P 
< 0.001 and from 11.9 ± 0.9 to 12.3 ± 0.9 g·kg- 1, +4.0%, P < 0.001) athletes following LHTL. 
Conclusion: The direct comparison study using individual data of endurance and team-sport 
athletes and strict methodological control (duplicate Hbmass-measures, matched-hypoxic dose) 
indicated that even athletes with higher initial Hbmass can reasonably expect Hbmass gain post-
LHTL. 
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Introduction 
Many elite endurance athletes perform altitude training with the aim to enhance their oxygen-
carrying capacity and eventually their sea-level performance (2, 24, 34). During the last decade, 
hypoxic/altitude training interventions have become increasingly popular in team sports and 
innovative methods fitting their physical requirements (combination of aerobic and anaerobic 
adaptations) have been introduced (3, 23). Compared to endurance athletes, team-sport athletes 
are generally characterised by a lower maximal aerobic capacity (11) and possess lower 
hemoglobin mass (Hbmass) (15, 31). The potential main benefit derived from the popular ‘live 
high–train low’ (LHTL) altitude training intervention seems to rely on an increase in Hbmass 
(13, 20, 33). In a particular sport (e.g. endurance or team sports), considerable individual 
variation in Hbmass response to altitude training has been reported (6, 8, 9, 14, 22, 29, 32). 
Although sources of this variability still remain unclear, aspects such as erythropoietic response 
to hypoxia (5, 6), genetic predisposition (35), residual fatigue and training history (7) and/or 
intra-individual conditions (32) likely play a role. 
Another suggested reason for this variability relies on the individual’s initial Hbmass level before 
embarking upon the altitude training camp. Hence, it has been proposed that athletes with 
already high initial Hbmass have a limited ability to further increase (i.e. ceiling effect) their 
Hbmass following altitude training (12, 22, 26). A recent analysis of nine LHTL studies (26) 
demonstrated a high correlation (r = 0.86, P < 0.01) between initial relative (expressed in 
g·kg- 1) Hbmass and post-intervention percentage increase in relative Hbmass. However, this 
analysis had several important limitations, which limit the strength of comparison between the 
different LHTL training studies. First, different methods (Evans blue dye vs. CO-rebreathing 
methods) for the determination of Hbmass, with different accuracy/reliability levels, have been 
used (33). Furthermore, these studies examined different genders (male and female), and 
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‘hypoxic doses’ varied greatly – between a total of 200–500 hours of hypoxic exposure. Lastly, 
the data analysis was based on averaged values and not on individual values. Nevertheless, one 
should be cautious when interpreting group mean data since considerable inter-individual 
variation in Hbmass response to altitude training exists (6, 8, 14, 22). 
Since LHTL is primarily used by elite endurance athletes typically presenting elevated Hbmass 
values compared to team-sport athletes, the hypothesis that athletes embarking on an LHTL 
camp with already high initial Hbmass have a limited ability to further increase their Hbmass post-
intervention (or at least to a lower extent than their team-sport counterparts) needs to be tested 
with a more robust study design. Thus, the aim of the present study was to examine the 
relationship between individual initial Hbmass prior to LHTL (absolute and relative values) and 
percentage Hbmass increase following a LHTL camp with comparable hypoxic doses in male 
endurance and team-sport athletes. 
 
 
Methods 
Study design 
Data from three altitude training interventions (studies I, II and III), with similar hypoxic doses 
(200–230 h) and identical Hbmass measurement procedures, were re-analysed to determine the 
nature of the association of individual Hbmass increase the individual initial absolute and relative 
Hbmass. The details of the experimental design of the three altitude training interventions have 
been published elsewhere (see Study I (27), Study II (14) and Study III (4)). 
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Participants 
For studies I and II, 35 well-trained male endurance athletes (age 24.0 ± 4.5 years, height 177.9 
± 4.8 cm, weight 70.2 ± 6.2 kg, endurance training experience ≥ 5 years) were recruited. These 
studies were approved by the local ethical committees (Commission Cantonale Valaisanne 
d’Ethique Médicale, CCVEM; Agreement 051/09 and French National Conference of Research 
Ethics Committees; N°CPP EST I: 2014/33; Dijon, France). For study III, 23 elite male field 
hockey players (age 24.4 ± 4.0 years, height 179.7 ± 9.1 cm, weight 77.5 ± 8.7 kg, training 7-9 
h per week) were included. This study was approved by the Anti-Doping Lab Qatar institutional 
review board (SCH-ADL-070; Doha, Qatar). A total of 58 athletes were included in the final 
study sample. Inclusion criteria were as follows: completion of an LHTL altitude training camp 
with all Hbmass measures done in duplicate by the same investigator prior to and after the 
intervention. All procedures were conducted in accordance with the Declaration of Helsinki 
guidelines, and all athletes provided written informed consent to participate in the respective 
studies. 
Altitude interventions 
For studies I and II (normobaric groups), 24 endurance athletes performed an 18-d LHTL 
altitude training camp under normobaric hypoxic conditions (~12.5 h·day-1 and 225 ± 9 h total 
hypoxic dose), during which the athletes trained at <1200 m and were exposed to normobaric 
hypoxia equivalent to 2250 m in hypoxic rooms (1150 m, PiO2 111.9 ± 0.6 mm Hg; FiO2 18.1 
± 0.1%; PB 666.6 ± 3.6 mm Hg). For study II (hypobaric group), since normobaric and 
hypobaric hypoxia induces similar Hbmass and endurance performance responses after LHTL 
altitude training(14, 27), an additional 11 endurance athletes were included, who completed a 
13-d LHTL camp under hypobaric hypoxic conditions with similar total hypoxic hours (230 ± 
1 h,  ̴17.5 h·day-1). Those athletes lived at 2250 m (PiO2 111.7 ± 0.7 mm Hg; FiO2 20.9%, PB 
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580.8 ± 3.3 mm Hg) and trained twice daily at <1200 m.  For study III, all 23 field hockey 
players performed a 14-d LHTL training camp under normobaric hypoxic conditions (> 14 
h·day-1 and  ̴198 h total hypoxic dose); thereby they trained at sea level and slept in normobaric 
hypoxic rooms, and simulated altitude was gradually increased from 2500 m (FiO2 15.1%, PB 
768.0 mm Hg, PiO2 108.3 mm Hg) up to 3000 m (FiO2 14.2 ± 0.1%, PB 765.3 ± 1.5 mm Hg, 
PiO2 101.7 ± 0.8 mm Hg) during the 14 days. In addition, they performed six repeated-sprints 
training sessions during the 14-d training camp either in normoxia (FiO2 20.9%; n=12) or 
normobaric hypoxic conditions (3000 m, FiO2  ̴14.5%; n=11). In summary, according to the 
definition of Garvican-Lewis et al. (10), the metrics for hypoxic dose (in km.h) between the 
LHTL groups were similar and differed within 6%, assuming that the present hypoxic doses 
were comparable. 
Hemoglobin mass  
In all athletes, Hbmass was measured in duplicate using a slightly modified version (30) of the 
optimised carbon monoxide (CO)-rebreathing method described by Schmidt and Prommer (28). 
For details, see Hauser et al. (14) and Brocherie et al. (4). Both measurements were performed 
on two consecutive days (12–24 h time lag between the measures), and the results were 
averaged. The typical error (TE) was calculated from duplicate measurements as the SD of the 
difference score divided by √2 (16). In our mobile laboratories, the TEs ranged between 1.6% 
and 2.0%. Since duplicate measurements reduce the TE by a factor of 1/√2 (16), the TEs for 
averaged duplicate Hbmass measurements ranged between 1.1% and 1.4%. For each athlete, 
Hbmass measures were performed by the same investigator throughout the studies. 
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Data analysis 
Values are presented as means ± standard deviation (SD). All data were checked for normality 
(Shapiro-Wilk test). Linear regressions were used to determine the Pearson’s product-moment 
correlation coefficients (r) between initial absolute and relative Hbmass and their respective 
percent changes in Hbmass, as well as for percent changes between body weight and Hbmass. The 
standard error (SE) of the slope of the linear regression was calculated by bootstrapping. 
Correlation size was interpreted using the correlation classification of Hopkins (17): trivial (r < 
0.1), small (0.1 < r < 0.3), moderate (0.3 < r < 0.5), large (0.5 < r < 0.7), very large (0.7 < r < 
0.9), nearly perfect (r > 0.9) and perfect (r = 1.0). Paired t-tests were conducted to compare pre- 
and post-values in Hbmass and body weight within the athlete group. An unpaired t-test was 
performed to compare percent changes between endurance and team-sport athletes. The level 
of significance was set at P < 0.05. All analyses were processed using Sigmaplot 11.0 (Systat 
Software, San Jose, CA) and the statistical software package R (Vienna, Austria). 
 
 
Results 
Relationship between initial Hbmass and Hbmass increase 
There was no relationship between the absolute initial Hbmass (g) and the percentage increase in 
absolute Hbmass (r = 0.02, P = 0.91) (Figure 1 A). The linear regression for absolute Hbmass was 
y = -0.0004x + 3.5 and the SE of the slope was ± 0.003. A moderate negative correlation 
between the relative initial Hbmass (g·kg-1) and the percentage increase in relative Hbmass (r = -
0.31, P = 0.02) was observed (Figure 1 B). The linear regression for relative Hbmass was y= -
0.98x + 16.4 and the SE of the slope was ± 0.348. 
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Mean Hbmass response 
Mean absolute Hbmass increased to the same extent in endurance (916 ± 88 to 951 ± 96 g, +3.8 
± 2.9%, P < 0.001) and team-sport (920 ± 120 to 957± 127 g, +4.0 ± 2.9%, P < 0.001) athletes 
(P = 0.81). Mean relative Hbmass increased equally in endurance (13.1 ± 1.2 to 13.6 ± 1.1 g·kg 1, 
+4.1 ± 4.2%, P < 0.001) and team-sport (11.9 ± 0.9 to 12.3 ± 0.9 g·kg-1, +4.0 ± 3.2%, P < 0.001) 
athletes (P = 0.94). 
Body weight 
The mean pre-body weight for endurance and team-sport athletes was 70.2 ± 6 kg and 77.5 ± 9 
kg, respectively, while the mean post-body weight was 70.0 ± 6 kg and 77.4 ± 8 kg, 
respectively. The changes pre- to post-body weight did not differ between the groups (P ≥ 0.53). 
There was no relationship (r = -0.006, P = 0.96) between individual percent changes in body 
weight and absolute Hbmass (Figure 2 A). A large inverse relationship (r = -0.64, P < 0.001) 
occurred between individual percent changes in body weight and relative Hbmass (Figure 2 B). 
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Figure 1. (A) Linear regression between the individual’s initial absolute Hbmass (g) and the individual’s absolute 
Hbmass change (%) following LHTL. (B) Linear regression between the individual’s initial relative Hbmass (g/kg) 
and the individual’s relative Hbmass change (%) following LHTL. Regression slope (solid line) and 95% confidence 
limits (dashed lines) are shown. n = 58. LHTL = live high–train low, RSH = repeated sprints in hypoxia, NH = 
normobaric hypoxia, HH = hypobaric hypoxia. 
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Figure 2. Linear regression between individual body weight change (%) and (A) individual absolute 
Hbmass change (%) and (B) individual relative Hbmass change (%) following LHTL. Regression slope 
(solid line) and 95% confidence limits (dashed lines) are shown. n = 58. 
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Discussion 
The present study demonstrated trivial (absolute values) to moderate (relative values) 
relationships between initial Hbmass and percentage change in Hbmass following LHTL altitude 
training in endurance and team-sport athletes. Mean absolute and relative Hbmass increased to 
the same extent in endurance and team-sport athletes following sport-specific LHTL 
interventions. Further, a large inverse relationship occurred between individual percent changes 
in body weight and relative Hbmass. 
Effect of absolute initial Hbmass on Hbmass response 
The observed trivial relationship (r = 0.02) between absolute initial Hbmass and percentage 
changes in absolute Hbmass might suggest that absolute initial Hbmass in our athlete cohort had 
no impact in regard to further Hbmass improvements following LHTL. Thus far, no study has 
focused on this relationship using absolute Hbmass values, with the rationale that absolute Hbmass 
values are not an indicator for an individual’s physiological limit (12, 21, 26). However, to 
precisely evaluate the sole effect of initial Hbmass on Hbmass response to altitude training both 
absolute and relative Hbmass values should be assessed to exclude the cofounding factor ‘body 
weight changes’ during altitude training. Further, the average percentage increase in absolute 
Hbmass was of a similar magnitude in endurance and team-sport athletes (+3.8 vs. +4.0%). This 
increase is in accordance with LHTL studies of similar total hypoxic hours (230–240 h), 
showing a measurable mean Hbmass increase in elite triathletes (+3.2%) (18) and semi-
professional Australian Footballers (+6.7%) (19). Thus, in the present sample absolute initial 
Hbmass demonstrated no adverse effect for further Hbmass improvement following LHTL. 
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Effect of relative initial Hbmass on Hbmass response 
We found a moderate inverse correlation between initial relative Hbmass and percentage increase 
in relative Hbmass (r = -0.31) following LHTL. Compared to the analysis of Robach and Lundby 
(26) and a classic altitude training study on Australian footballers (22), the present correlation 
coefficient was much smaller than in those studies (r = -0.51 to -0.86). The above mentioned 
studies suggested that athletes starting with high relative Hbmass levels have smaller chances to 
further increase their relative Hbmass following altitude training, with the rationale that those 
athletes would already have maximised their Hbmass level by training at sea level (22, 26). 
However, in the present study it seems that the moderate inverse relationship between initial 
relative Hbmass and percent change in relative Hbmass could not be attributed to the physiological 
limit of an athlete. 
Changes in an individual’s body weight from pre- to post- intervention could explain the 
moderate relationship between initial relative Hbmass and its percentage Hbmass increase 
following LHTL. There was a large inverse relationship (r = -0.64) between individual percent 
changes in body weight and relative Hbmass, whereas no relationship between individual percent 
changes in body weight and absolute Hbmass occurred. This assumes that, primarily, individual 
changes in body weight from pre- to post LHTL camp led to the moderate relationship between 
initial relative Hbmass and percent change in Hbmass following LHTL camp. Whether the body 
weight changes were due to alterations in fat and/ or muscle mass or because of the weekly 
fluctuation in body weight/ fluid (25) remains unclear. With a lack of significant relationship 
between individual changes in body weight and absolute Hbmass, it can be assumed that body 
weight alterations did not negatively influence Hbmass response in the present study. Thus, we 
propose that lean body mass- adjusted relative Hbmass values would be a better unit for future 
comparisons. 
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A further point that must be considered when assessing the relationship between change and 
initial values, is the statistical phenomon ‘regression to the mean’ (1). Although in the present 
study there was no relationship between initial absolute Hbmass and percent changes in absolute 
Hbmass, the ‘regression to the mean’ effect could have still appeared. Further, since in the present 
study individual changes in body weight from pre- to post-LHTL camp occurred, it could also 
be possible that the ‘regression to the mean’ effect arose within the relationship between initial 
body weight and body weight changes. This makes the speculation that part of the inverse 
relationship between initial relative Hbmass and percent changes in relative Hbmass following 
LHTL camp could be due to the statistical phenomenon ‘regression to the mean’. However, this 
needs to be confirmed with a larger dataset, involving athletes of different performance levels 
and from various sport disciplines as well as using different altitude training paradigms with 
various characteristics (duration, altitude severity, type of hypoxia, etc.).  
 
 
Conclusion 
Our results indicate that trivial (absolute values) to moderate (relative values) relationships 
occurred between initial Hbmass and Hbmass increase following LHTL altitude training in 
endurance and team-sport athletes. This indicates that even athletes with higher initial Hbmass 
can reasonably expect Hbmass gains post-LHTL. Further, it seems that in the present study the 
moderate relationship between initial relative Hbmass and percentage increase in relative Hbmass 
following LHTL could be attributed to changes in body weight and possibly to the statistical 
phenomenon ‘regression to the mean’, rather than to a pure physiological effect. 
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